XML 15 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2020	Mar. 12, 2021	Jun. 30, 2020
Cover
Entity Registrant Name	RETRACTABLE TECHNOLOGIES INC
Entity Central Index Key	0000946563
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		33,982,604
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Public Float			$ 121,416,123
Trading Symbol	RVP
Title of 12(b) Security	Common
Security Exchange Name	NYSE

XML 16 R2.htm IDEA: XBRL DOCUMENT

BALANCE SHEETS - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 17,566,682	$ 5,934,749
Accounts receivable, net of allowance for doubtful accounts of $205,822 and $146,832	32,910,919	6,564,371
Investments in debt and equity securities, at fair value	8,081,833	7,771,660
Inventories, net	10,234,646	7,450,592
Income taxes receivable		50,392
Other current assets	684,317	635,201
Total current assets	69,478,397	28,406,965
Property, plant, and equipment, net	30,816,504	10,632,057
Income taxes receivable		50,393
Deferred tax asset	4,631,206
Other assets	44,567	88,315
Total assets	104,970,674	39,177,730
Current liabilities:
Accounts payable	16,256,444	5,007,604
Current portion of long-term debt	1,030,763	260,939
Accrued compensation	826,762	607,339
Dividends payable	49,091	54,800
Accrued royalties to shareholder	1,973,781	921,445
Other accrued liabilities	3,398,904	1,387,149
Income taxes payable	4,365,770	17,944
Total current liabilities	27,901,515	8,257,220
Other long-term liabilities	24,478,697
Long-term debt, net of current maturities	2,710,337	2,378,055
Total liabilities	55,090,549	10,635,275
Commitments and contingencies - See Note 10
Preferred stock, $1 par value:
Common Stock, no par value; authorized: 100,000,000 shares; outstanding: 33,956,204 and 32,674,954 shares at December 31, 2020 and 2019
Additional paid-in capital	59,285,401	61,660,744
Accumulated deficit	(9,668,221)	(33,891,234)
Total stockholders' equity	49,880,125	28,542,455
Total liabilities and stockholders' equity	104,970,674	39,177,730
Series I, Class B
Preferred stock, $1 par value:
Preferred stock		96,000
Series II, Class B
Preferred stock, $1 par value:
Preferred stock	156,200	171,200
Series III Preferred Stock
Preferred stock, $1 par value:
Preferred stock	$ 106,745	129,245
Series IV Preferred Stock
Preferred stock, $1 par value:
Preferred stock		342,500
Series V Preferred Stock
Preferred stock, $1 par value:
Preferred stock		$ 34,000

XML 17 R3.htm IDEA: XBRL DOCUMENT

BALANCE SHEETS (Parenthetical) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 205,822	$ 146,832
Common stock, par value (in dollars per share)	$ 0	$ 0
Common Stock, authorized shares	100,000,000	100,000,000
Common Stock, outstanding shares	33,957,204	32,674,954
Preferred Class B
Preferred stock, par value (in dollars per share)	$ 1.00
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Series I, Class B
Preferred stock, par value (in dollars per share)	$ 1
Preferred Stock, outstanding shares	0	96,000
Series II, Class B
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred Stock, outstanding shares	156,200	171,200
Preferred Stock, liquidation preference (in dollars)	$ 1,952,500
Series III Preferred Stock
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred Stock, outstanding shares	106,745	129,245
Preferred Stock, liquidation preference (in dollars)	$ 1,334,313
Series IV Preferred Stock
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred Stock, outstanding shares	0	342,500
Series V Preferred Stock
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred Stock, outstanding shares	0	34,000

XML 18 R4.htm IDEA: XBRL DOCUMENT

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
STATEMENTS OF OPERATIONS - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Sales, net	$ 81,862,453	$ 41,797,179	$ 33,274,702
Cost of sales
Total cost of sales	44,854,100	27,659,223	23,052,900
Gross profit	37,008,353	14,137,956	10,221,802
Operating expenses:
Sales and marketing	4,061,904	4,217,863	4,404,441
Research and development	574,527	516,095	621,365
General and administrative	8,301,169	6,432,158	6,786,041
Total operating expenses	12,937,600	11,166,116	11,811,847
Income from insurance proceeds			260,514
Income (loss) from operations	24,070,753	2,971,840	(1,329,531)
Interest and other income	2,262,758	351,166	153,460
Interest expense	(260,264)	(166,897)	(177,190)
Income (loss) before income taxes	26,073,247	3,156,109	(1,353,261)
Provision (benefit) for income taxes	1,850,234	7,875	(13,318)
Net income (loss)	24,223,013	3,148,234	(1,339,943)
Preferred Stock dividend requirements	(573,868)	(702,618)	(704,996)
Deemed contribution on extinguishment of preferred stock	2,975,708
Income (loss) applicable to common shareholders	$ 26,624,853	$ 2,445,616	$ (2,044,939)
Basic earnings (loss) per share	$ 0.80	$ 0.07	$ (0.06)
Diluted earnings (loss) per share	$ 0.80	$ 0.07	$ (0.06)
Weighted average common shares outstanding:
Basic (in shares)	33,169,307	32,672,475	32,666,454
Diluted (in shares)	33,300,654	32,672,475	32,666,454
Costs of manufactured product
Cost of sales
Total cost of sales	$ 39,377,794	$ 24,209,401	$ 20,108,798
Royalty expense to shareholder
Cost of sales
Total cost of sales	$ 5,476,306	$ 3,449,822	$ 2,944,102

XML 19 R5.htm IDEA: XBRL DOCUMENT

STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Common Stock	Preferred Stock Series I, Class B	Preferred Stock Series II, Class B	Preferred Stock Series III Preferred Stock	Preferred Stock Series IV Preferred Stock	Preferred Stock Series V Preferred Stock	Additional Paid-in Capital	Accumulated Deficit	Series I, Class B	Series III Preferred Stock	Series V Preferred Stock	Total
Balance at Dec. 31, 2017		$ 98,500	$ 171,200	$ 129,245	$ 342,500	$ 40,000	$ 62,092,206	$ (35,699,525)				$ 27,174,126
Balance (in shares) at Dec. 31, 2017	32,666,454	98,500	171,200	129,245	342,500	40,000
Increase (Decrease) in Stockholders' Equity
Dividends							(220,450)					(220,450)
Net income (loss)								(1,339,943)				(1,339,943)
Balance at Dec. 31, 2018		$ 98,500	$ 171,200	$ 129,245	$ 342,500	$ 40,000	61,871,756	(37,039,468)				25,613,733
Balance (in shares) at Dec. 31, 2018	32,666,454	98,500	171,200	129,245	342,500	40,000
Increase (Decrease) in Stockholders' Equity
Conversion of Preferred Stock into Common Stock (in Shares)	8,500	(2,500)				(6,000)			2,500		6,000
Dividends							(219,512)					(219,512)
Conversion of Preferred Stock into Common Stock		$ (2,500)				$ (6,000)	8,500
Net income (loss)								3,148,234				3,148,234
Balance at Dec. 31, 2019		$ 96,000	$ 171,200	$ 129,245	$ 342,500	$ 34,000	61,660,744	(33,891,234)				28,542,455
Balance (in shares) at Dec. 31, 2019	32,674,954	96,000	171,200	129,245	342,500	34,000
Increase (Decrease) in Stockholders' Equity
Exchange of Preferred Stock for Common Stock				$ (22,500)	$ (342,500)	$ (34,000)	(3,090,672)					(3,489,672)
Exchange of Preferred Stock for Common Stock (in shares)	754,000				(342,500)	(34,000)
Stock Option Exercises	$ 431,550						922,512					922,512
Redemption		$ (14,300)					(92,950)		$ (107,250)			(107,250)
Redemption (in shares)		(14,300)							14,300
Conversion of Preferred Stock into Common Stock (in Shares)	96,700	(81,700)	(15,000)						81,700	22,500	0
Dividends							(210,933)					(210,933)
Conversion of Preferred Stock into Common Stock		$ (81,700)	$ (15,000)				96,700
Net income (loss)								24,223,013				24,223,013
Balance at Dec. 31, 2020			$ 156,200	$ 106,745			$ 59,285,401	$ (9,668,221)				$ 49,880,125
Balance (in shares) at Dec. 31, 2020	33,957,204		156,200	106,745

XML 20 R6.htm IDEA: XBRL DOCUMENT

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
STATEMENTS OF CASH FLOWS - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities
Net income (loss)	$ 24,223,013	$ 3,148,234	$ (1,339,943)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization	832,069	852,080	886,814
Realized gains on investments	(162,595)	(7,925)
Net unrealized gains on investments	(1,870,010)	(129,315)
Deferred taxes	(4,631,206)
Inventories reserve			(297,731)
Provision for doubtful accounts, net of write-offs	59,440		47,793
Loss on disposal of assets	33,140
(Increase) decrease in operating assets:
Accounts receivable	(14,626,910)	(1,652,015)	145,407
Inventories	(2,784,054)	94,502	(1,041,202)
Other current assets	(49,116)	9,602	(226,649)
Income taxes receivable	100,785	100,937	(13,266)
Other assets	43,748	77,541
Increase (decrease) in operating liabilities:
Accounts payable	11,248,840	(362,072)	411,927
Accrued liabilities	2,232,059	55,150	699,030
Insurance proceeds			(466,293)
Income taxes payable	4,347,826	7,919	(1,382)
Net cash provided (used) by operating activities	18,997,029	2,194,638	(1,195,495)
Cash flows from investing activities:
Purchase of property, plant, and equipment	(21,049,656)	(632,078)	(382,156)
Purchase of debt and equity securities	(2,242,897)	(7,360,398)	(2,986,156)
Proceeds from the sales of debt and equity securities	3,965,329	2,712,134
Net cash used by investing activities	(19,327,224)	(5,280,342)	(3,368,312)
Cash flows from financing activities:
Proceeds of long-term debt	1,363,000
Repayments of long-term debt	(260,894)	(407,014)	(446,350)
Proceeds from TIA	10,636,822
Proceeds from the exercise of stock options	922,512
Repurchase of preferred stock	(482,670)
Payment of preferred stock dividends	(216,642)	(219,825)	(220,450)
Net cash provided (used) by financing activities	11,962,128	(626,839)	(666,800)
Net increase (decrease) in cash and cash equivalents	11,631,933	(3,712,543)	(5,230,607)
Cash and cash equivalents at:
Beginning of period	5,934,749	9,647,292	14,877,899
End of period	17,566,682	5,934,749	9,647,292
Supplemental schedule of cash flow information:
Interest paid	260,264	166,897	177,190
Income taxes paid	2,106,000		1,173
Supplemental schedule of noncash investing and financing activities:
Preferred dividends declared, not paid	49,091	54,800	$ 55,113
Conversion of preferred stock to common stock	96,700	$ 8,500
Redemption price payable	107,250
Preferred stock repurchase payable	3,007,002
Amounts receivable under TIA	$ 11,779,078

XML 21 R7.htm IDEA: XBRL DOCUMENT

BUSINESS OF THE COMPANY AND BASIS OF PRESENTATION	12 Months Ended
BUSINESS OF THE COMPANY AND BASIS OF PRESENTATION	Dec. 31, 2020
BUSINESS OF THE COMPANY AND BASIS OF PRESENTATION
BUSINESS OF THE COMPANY AND BASIS OF PRESENTATION	1. BUSINESS OF THE COMPANY AND BASIS OF PRESENTATION Business of the Company Retractable Technologies, Inc. (the “Company”) was incorporated in Texas on May 9, 1994, and designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The Company began to develop its manufacturing operations in 1995. The Company’s manufacturing and administrative facilities are located in Little Elm, Texas. The Company’s products are the VanishPoint® 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe® syringes; the Patient Safe® Luer Cap; the VanishPoint® Blood Collection Set; and the EasyPoint® needle, as well as a standard 3mL syringe packaged with an EasyPoint® needle. The Company also sells VanishPoint® autodisable syringes in the international market in addition to the Company’s other products.

XML 22 R8.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2020

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.

Cash and cash equivalents

For purposes of reporting cash flows, cash and cash equivalents include cash, money market accounts, and investments with original maturities of three months or less.

Accounts receivable

The Company records trade receivables when revenue is recognized. No product has been consigned to customers. The Company’s allowance for doubtful accounts is primarily determined by review of specific trade receivables. Those accounts that are doubtful of collection are included in the allowance. This provision is reviewed to determine the adequacy of the allowance for doubtful accounts. Trade receivables are charged off when there is certainty as to their being uncollectible. Trade receivables are considered delinquent when payment has not been made within contract terms.

The Company requires certain customers to make a prepayment prior to beginning production or shipment of their order. Customers may apply such prepayments to their outstanding invoices or pay the invoice and continue to carry forward the deposit for future orders. Such amounts are included in Other accrued liabilities on the Balance Sheets and are shown in Note 7, Other Accrued Liabilities.

The Company records an allowance for estimated returns as a reduction to Accounts receivable and Gross sales. Historically, returns have been insignificant.

Inventories

Inventories are valued at the lower of cost or net realizable value, with cost being determined using actual average cost. The Company compares the average cost to the net realizable value and records the lower value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Management considers such factors as the amount of inventory on hand and in the distribution channel, estimated time to sell such inventory, the shelf life of inventory, and current market conditions when determining excess or obsolete inventories. A reserve is established for any excess or obsolete inventories or they may be written off.

Investments in debt and equity securities

The Company holds high-grade exchange-traded and closed-end funds (ETFs), mutual funds,equity securities, and debt securities as investments. These assets are readily marketable and are carried at fair value as of the date of the Balance Sheets. Net unrealized and realized gains or losses on investments in debt and equity securities are reflected as a component of Interest and other income. Realized gains or losses on investments in debt and equity securities are recognized using the specific identification method.

Property, plant, and equipment

Property, plant, and equipment are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. Cost includes major expenditures for improvements and replacements which extend useful lives or increase capacity and interest cost associated with significant capital additions. Gains or losses from disposals are included in operations.

The Company's property, plant, and equipment primarily consist of buildings, land, assembly equipment, molding machines, molds, office equipment, furniture, and fixtures. Depreciation and amortization are calculated using the straight-line method over the following useful lives:


Production equipment		3 to 13 years
Office furniture and equipment		3 to 10 years
Buildings		39 years
Building improvements		15 years

Long-lived assets

The Company assesses the recoverability of long-lived assets using an assessment of the estimated undiscounted future cash flows related to such assets. In the event that assets are found to be carried at amounts which are in excess of estimated gross future cash flows, the assets will be adjusted for impairment to a level commensurate with fair value determined using a discounted cash flow analysis or appraised values of the underlying assets.

Fair value measurements

For assets and liabilities that are measured using quoted prices in active markets, total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs. Assets and liabilities that are measured using significant other observable inputs are valued by reference to similar assets or liabilities, adjusted for contract restrictions and other terms specific to that asset or liability. For these items, a significant portion of fair value is derived by reference to quoted prices of similar assets or liabilities in active markets. For all remaining assets and liabilities, fair value is derived using a fair value model, such as a discounted cash flow model or Black-Scholes model.

Financial instruments

The Company estimates the fair value of financial instruments through the use of public market prices, quotes from financial institutions, and other available information. Judgment is required in interpreting data to develop estimates of fair value and, accordingly, amounts are not necessarily indicative of the amounts that could be realized in a current market exchange. Short-term financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and other liabilities, consist primarily of instruments without extended maturities, the fair value of which, based on Management’s estimates, equals their recorded values. Investments in equity securities consist primarily of individual equity securities, exchange-traded and closed-end funds and mutual funds and are reported at their fair value based upon quoted prices in active markets. Investments in U.S. Treasury Notes are reported at their fair value based upon quoted prices in active markets. Investments in certificates of deposit (CD) with original maturities of greater than three months are reported at their estimated fair value based upon the duration of the CD and the interest rate earned on the CD versus current interest rates of similar duration CDs. The fair value of long-term liabilities, based on Management’s estimates, approximates their reported values.

Concentration risks

The Company’s financial instruments exposed to concentrations of credit risk consist primarily of cash, cash equivalents, certificates of deposit, U.S. Treasury Notes, exchange-traded and closed-end funds, mutual funds, equity securities, and accounts receivable. Cash balances, some of which exceed federally insured limits, are maintained in financial institutions; however, Management believes the institutions are of high credit quality. The majority of accounts receivable are due from companies that are well-established entities. The Company assesses market risk in debt and equity securities through consultation with its outside investment advisors. Management is responsible for directing investment activity based on current economic conditions. In 2020, a significant portion of the Company's sales were to the U.S. government, which Management does not consider a credit risk. As a consequence, Management considers any exposure from concentrations of credit risks to be limited.

The following table reflects our significant customers in 2020, 2019, and 2018:


	Years Ended December 31,
	2020			2019			2018
Number of significant customers		2			3			2
Aggregate dollar amount of net sales to significant customers	$	41.6 million		$	19.0 million		$	13.1 million
Percentage of net sales to significant customers		50.6	%		45.6	%		39.2	%

The Company increased its allowance for doubtful accounts by approximately $125 thousand in 2020.

In 2020, approximately $31.6 million of the Company's sales were to the Department of Health and Human Services of the United States in partial fulfillment of a recent $83.8 million delivery order to supply automated retraction safety syringes (the "HHS Order"). Management expects the U.S. government to remain a significant customer through at least July 2021.

The Company manufactures some of its products in Little Elm, Texas, as well as utilizing manufacturers in China. The Company obtained roughly 85.2% of its products in 2020 from its Chinese manufacturers. Purchases from Chinese manufacturers aggregated 82.6% and 85.3% of products in 2019 and 2018, respectively. In the event that the Company becomes unable to purchase products from its Chinese manufacturers, the Company would need to find an alternate manufacturer for its blood collection set, IV catheter, Patient Safe® syringe, 0.5mL insulin syringe, 0.5mL autodisable syringe, and 2mL, 5mL, and 10mL syringes and would increase domestic production for the 1mL and 3mL syringes and EasyPoint® needles. Regardless of vendor availability, the Company expects to increase its domestic syringe production capacity at its facilities pursuant to the plans outlined in the TIA as hereinafter defined.

Revenue recognition

The Company recognizes revenue when it has satisfied all performance obligations to the customer, generally when title and risk of loss pass to the customer. Payments from customers with approved credit terms are typically due 30 days from the invoice date. Under certain contracts, revenue is recorded on the basis of sales price to distributors, less contractual pricing allowances. Contractual pricing allowances consist of: (i) rebates granted to distributors who provide tracking reports which show, among other things, the facility that purchased the products, and (ii) a provision for estimated contractual pricing allowances for products for which the Company has not received tracking reports. Rebates are recorded when issued and are applied against the customer’s receivable balance. Distributors receive a rebate for the difference between the Wholesale Acquisition Cost and the appropriate contract price as reflected on a tracking report provided by the distributor to the Company. If product is sold by a distributor to an entity that has no contract, there is a standard rebate (lower than a contracted rebate) given to the distributor. One of the purposes of the rebate is to encourage distributors to submit tracking reports to the Company. The provision for contractual pricing allowances is recognized in the period the related sales are recognized and is reviewed at the end of each quarter and adjusted for changes in levels of products for which there is no tracking report. Additionally, if it becomes clear that tracking reports will not be provided by individual distributors, the provision is further adjusted. The estimated contractual allowance is included in Accounts payable in the Balance Sheets and deducted from revenues in the Statements of Operations. Accounts payable included estimated contractual allowances for $3,435,352 and $3,586,726 as of December 31, 2020 and 2019, respectively. The terms and conditions of contractual pricing allowances are governed by contracts between the Company and its distributors. Revenue for shipments directly to end-users is recognized when title and risk of ownership pass from the Company. End-users do not receive any contractual allowances on their purchases. Any product shipped or distributed for evaluation purposes is expensed.

The Company provides product warranties that: i) the products are fit for medical use as generally defined within the boundaries of United States FDA approval; ii) the products are not defective; and iii) the products will conform to the descriptions set forth in their respective labeling, provided that they are used in accordance with such labeling and the Company’s written directions for use. The Company has historically not incurred significant warranty claims.

The Company’s domestic return policy provides that a customer may return incorrect shipments within 10 days following arrival at the distributor’s facility. In all such cases, the distributor must obtain an authorization code from the Company and affix the code to the returned product.

The Company’s domestic return policy also generally provides that a customer may return product that is overstocked. Overstocking returns are limited to two times in each 12-month period up to 1% of distributor’s total purchase of products for the prior 12-month period. All product overstocks and returns are subject to inspection and acceptance by the Company.

The Company’s international distribution agreements generally do not provide for any returns.

The Company requires certain customers to pay in advance of product shipment. Such prepayments from customers are recorded in Other accrued liabilities and are generally recognized as revenue upon shipment of the product .

The Company recognizes revenue from licensing agreements when collection of such amounts from third parties is reasonably assured. If the Company licenses its products for sale, the Company is obligated to pay Thomas J. Shaw, the owner of certain patented technology, a certain percentage of such revenue pursuant to the terms of the Technology License Agreement between the Company and Mr. Shaw.

Disaggregated information of revenue recognized from contracts with customers and licensing fees recognized are as follows:


	For the year ended December 31, 2020:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales (excluding HHS Order)	$	30,446,858	$	2,116,108	$	9,542,122	$	64,375	$	42,169,463
HHS Order sales to U.S. government		31,634,343		—		—		—		31,634,343
North and South America sales (excluding U.S.)		5,733,116		8,450		86,816		1,064,768		6,893,150
Other international sales		917,478		239,329		235		8,455		1,165,497
Total	$	68,731,795	$	2,363,887	$	9,629,173	$	1,137,598	$	81,862,453


	For the year ended December 31, 2019:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales	$	26,722,414	$	2,130,767	$	2,970,374	$	74,369	$	31,897,924
North and South America sales (excluding U.S.)		7,863,796		6,313		7,996		370,885		8,248,990
Other international sales		1,052,217		578,617		635		18,796		1,650,265
Total	$	35,638,427	$	2,715,697	$	2,979,005	$	464,050	$	41,797,179


	For the year ended December 31, 2018:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales	$	23,803,483	$	1,365,936	$	3,401,389	$	75,766	$	28,646,574
North and South America sales (excluding U.S.)		3,521,823		8,805		252		66,564		3,597,444
Other international sales		940,740		48,101		11,768		30,075		1,030,684
Total	$	28,266,046	$	1,422,842	$	3,413,409	$	172,405	$	33,274,702

Income taxes

The Company evaluates tax positions taken or expected to be taken in a tax return for recognition in the financial statements based on whether it is “more-likely-than-not” that a tax position will be sustained based upon the technical merits of the position. Measurement of the tax position is based upon the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.

The Company provides for deferred income taxes through utilizing an asset and liability approach for financial accounting and reporting based on the tax effects of differences between the financial statement and tax bases of assets and liabilities, based on enacted rates expected to be in effect when such differences reverse in future periods. Deferred tax assets are periodically reviewed for realizability.In prior periods, the Company established a valuation allowance for its net deferred tax asset as future taxable income which could not be reasonably assured. Penalties and interest related to income taxes are classified as General and administrative expense and Interest expense, respectively. During the quarter ended June 30, 2020, the Company released its valuation allowance based on available evidence supporting that its deferred tax assets will be realized in full.

Earnings per share

The Company computes basic earnings or loss per share (“EPS”) by dividing net earnings or loss for the period (adjusted for any cumulative dividends for the period) by the weighted average number of common shares outstanding during the period. Diluted EPS includes the determinants of basic EPS and, in addition, reflects the dilutive effect, if any, of the common stock deliverable pursuant to stock options or common stock issuable upon the conversion of convertible preferred stock. At December 31, 2020, the calculation of diluted EPS under the treasury stock method included 131,347 shares of Common Stock underlying issued and outstanding stock options. Common stock issuable upon the conversion of convertible preferred stock is excluded from the calculation of diluted EPS for 2020, 2019, and 2018 because the effect was antidilutive. At December 31, 2019 and December 31, 2018, the calculation of diluted EPS excluded 639,300 and 1,357,803 shares of common stock, respectively, underlying issued and outstanding stock options, as the exercise prices of the stock options were greater than the average stock prices. The potential dilution, if any, is shown on the following schedule:


	Years Ended December 31,
	2020		2019		2018
Net income (loss)	$	24,223,013	$	3,148,234	$	(1,339,943)
Preferred stock dividend requirements		(573,868)		(702,618)		(704,996)
Deemed contribution on extinguishment of preferred stock		2,975,708		—		—
Income (loss) applicable to common stockholders	$	26,624,853	$	2,445,616	$	(2,044,939)

Weighted Average common shares outstanding		33,169,307		32,672,475		32,666,454
Weighted Average common and common equivalent shares outstanding - assuming dilution		33,300,654		32,672,475		32,666,454
Basic earnings (loss) per share	$	0.80	$	0.07	$	(0.06)
Diluted earnings (loss) per share	$	0.80	$	0.07	$	(0.06)

The FASB Codification 260-10-S99-2, Effect on the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock, requires the gain or loss on extinguishment of equity-classified preferred stock to be included in the net income per common stockholder used to calculate earnings per share (similar to the treatment of dividends paid on preferred stock). The difference between (1) the fair value of the consideration transferred to the holders of the preferred stock and (2) the carrying amount of the preferred stock (net of issuance costs) is subtracted from (or added to) net income to arrive at income available to common stockholders in the calculation of earnings per share.

The Company has determined to apply this guidance to its accounting treatment of the preferred stock transactions described in Note 19.

Shipping and handling costs

The Company classifies shipping and handling costs as part of Cost of sales in the Statements of Operations.

Self-insured employee benefit costs

The Company self-insures certain health insurance benefits for its employees under certain policy limits. The Company has additional coverage provided by an insurance company for any individual with claims in excess of $100,000 and/or total plan claims in excess of $1,000,000 for the plan year.

Research and development costs

Research and development costs are expensed as incurred.

Share-based compensation

The Company’s share-based payments are accounted for using the Black-Scholes fair value method. The Company records share-based compensation expense on a straight-line basis over the requisite service period.

Insurance Proceeds

Receipts from insurance, up to the amount of any loss recognized by the Company, are considered recoveries. Any such recoveries are recorded when they are received. Insurance proceeds are not recognized as a component of income (loss) from operations until all repairs are made.

Leases

The Company determines if an arrangement is a lease at inception. Operating and finance leases are included in Other assets, Other accrued liabilities, and Other long-term liabilities on the Balance Sheets. Right-of-use ("ROU") assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As the Company's leases do not provide an implicit rate, the incremental borrowing rate based on information available at the commencement date was used in determining the present value of lease payments.

The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of twelve months or less are not recorded on the Balance Sheets; however, rent expense is recognized on a straight-line basis over the lease term.

Technology Investment Agreement (TIA)

Effective July 1, 2020, the Company entered into a Technology Investment Agreement ("TIA") with the United States Government Department of Defense, U.S. Army Contracting Command-Aberdeen Proving Ground, Natick Contracting Division & Edgewood Contracting Division (ACC-APG, NCD & ECD) on behalf of the Biomedical Advanced Research and Development Authority (BARDA) for $53,664,286 in government funding for expanding the Company's domestic production of needles and syringes. Pursuant to the terms of the TIA, the Company is expected to make significant additions to its facilities which should allow the Company to increase domestic production. As reimbursements are received from the U.S. government for such expenditures, the Company records a deferred liability. The deferred liability will be systematically amortized as a gain over the life of the related property, plant, and equipment as to offset the related depreciation expense of the assets acquired. The amortization will be presented separately from the depreciation expense on the Statements of Operations.

Recently Adopted Pronouncements

The Company adopted ASU 2016-13, “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ,” as well as subsequent clarifying amendments on January 1, 2020. Among other things, these amendments require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Many of the loss estimation techniques applied previously will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. The adoption of ASU 2016-13, as well as the Targeted Transition Relief as provided by ASU 2019-05, "Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief " did not have a significant impact on the Company's financial statements.

The Company adopted ASU 2018-15, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract (a Consensus of the FASB Emerging Issues Task Force)” on January 1, 2020. This amendment requires that implemented costs incurred in a hosting arrangement that is a service contract should be accounted for in accordance with ASC 350-40 Internal- Use Software. Accordingly, costs incurred during the preliminary project and post-implementation stages are expensed and costs associated with the application development phase are capitalized. The amendment also requires that capitalized costs be amortized over the term of the hosting arrangement and that capitalized costs should be evaluated for impairment. The adoption of this ASU did not have a significant impact on the Company's financial statements or disclosures.

In August 2018, the FASB issued ASU 2018-13 "Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement." The amendment modifies, among other things, disclosure requirements on fair value measurements and eliminates certain disclosures related to transfers and valuation levels of Level 3 fair value measurements. Additionally, the amendment requires disclosure of changes in unrealized gains and losses in other comprehensive income for Level 3 fair value measurements and certain qualitative factors related to significant unobservable inputs used in Level 3 valuations. The amendment was effective for annual periods beginning after December 15, 2019 and interim periods within the annual period. The adoption of ASU 2018-13 did not have a significant effect on the Company's financial statements, as the Company does not currently have any investments classified as Level 3 fair value measurements.

Recently Issued Pronouncements

In December 2019, the FASB issued ASU 2019-12, “Income Taxes: Simplifying the Accounting for Income Taxes”. The new standard is intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within the annual period, with early adoption permitted. Adoption of the standard requires certain changes primarily be made prospectively, with some changes to be made retrospectively. The Company has determined that the adoption of ASU 2019-12 will not have a material impact on its financial statements.

In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients for contracts that reference LIBOR, if certain criteria are met, that can be applied through December 31, 2022. As reference rate reform is still an ongoing process, the Company will continue to evaluate the timing and potential impact of adoption for optional expedients when deemed necessary.

XML 23 R9.htm IDEA: XBRL DOCUMENT

INVENTORIES

12 Months Ended

Dec. 31, 2020

INVENTORIES

INVENTORIES

3. INVENTORIES

Inventories consist of the following:


	December 31,
	2020		2019
Raw materials	$	1,358,552	$	1,254,313
Finished goods		9,173,302		6,493,487
		10,531,854		7,747,800
Inventory reserve		(297,208)		(297,208)
	$	10,234,646	$	7,450,592

XML 24 R10.htm IDEA: XBRL DOCUMENT

FAIR VALUE OF FINANCIAL INSTRUMENTS

12 Months Ended

Dec. 31, 2020

FAIR VALUE OF FINANCIAL INSTRUMENTS

FAIR VALUE OF FINANCIAL INSTRUMENTS

4. FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC 820, “Fair Value Measurements”, defines fair value, establishes a framework for measuring fair value and requires additional disclosures regarding certain fair value measurements. ASC 820 establishes a three-tier hierarchy for measuring fair value, as follows:

Level 1 – quoted market prices in active markets for identical assets and liabilities

Level 2 – inputs other than quoted prices that are directly or indirectly observable

Level 3 - unobservable inputs where there is little or no market activity

The following tables summarize the values of assets designated as Investments in debt and equity securities:


	December 31, 2020
	Level 1		Level 2		Level 3		Total
Equity securities	$	3,990,533	$	—	$	—	$	3,990,533
Mutual funds and exchange traded funds		4,013,956		—		—		4,013,956
Certificates of deposit		—		77,344		—		77,344
	$	8,004,489	$	77,344	$	—	$	8,081,833


	December 31, 2019
	Level 1		Level 2		Level 3		Total
Mutual funds and exchange traded funds	$	6,708,746	$	—	$	—	$	6,708,746
Certificates of deposit		—		1,062,914		—		1,062,914
	$	6,708,746	$	1,062,914	$	—	$	7,771,660

The Company holds high-grade ETFs, mutual funds, individual equity stocks, and debt securities as investments. These assets are readily marketable and are carried at fair value as of the date of the Balance Sheets. The Company intends to hold these assets for possible future operating requirements.

The following table summarizes gross unrealized gains and losses from Investments in debt and equity securities:


	December 31, 2020
			Gross Unrealized				Aggregate
	Cost		Gains		Losses		Fair Value
Equity securities	$	2,098,144	$	1,892,389	$	—	$	3,990,533
Mutual funds and exchange traded funds		3,909,364		104,592		—		4,013,956
Certificates of deposit		75,000		2,344		—		77,344
	$	6,082,508	$	1,999,325	$	—	$	8,081,833


	December 31, 2019
			Gross Unrealized				Aggregate
	Cost		Gains		Losses		Fair Value
Mutual funds and exchange traded funds	$	6,592,345	$	116,401	$	—	$	6,708,746
Certificates of deposit		1,050,000		12,914		—		1,062,914
	$	7,642,345	$	129,315	$	—	$	7,771,660

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 25 R11.htm IDEA: XBRL DOCUMENT

PROPERTY, PLANT, AND EQUIPMENT

12 Months Ended

Dec. 31, 2020

PROPERTY, PLANT, AND EQUIPMENT

PROPERTY, PLANT, AND EQUIPMENT

5. PROPERTY, PLANT, AND EQUIPMENT

Property, plant, and equipment consist of the following:


	December 31,
	2020		2019

Land	$	261,893	$	261,893
Buildings and building improvements		11,593,952		11,566,115
Production equipment		20,290,331		19,903,236
Office furniture and equipment		3,630,455		3,527,577
Construction in progress		21,365,915		765,176
		57,142,546		36,023,997
Accumulated depreciation		(26,326,042)		(25,391,940)
	$	30,816,504	$	10,632,057

Depreciation expense for the years ended December 31, 2020, 2019, and 2018 was $832,069; $851,673; and $883,610, respectively.

XML 26 R12.htm IDEA: XBRL DOCUMENT

LICENSE AGREEMENT	12 Months Ended
LICENSE AGREEMENT	Dec. 31, 2020
LICENSE AGREEMENT
LICENSE AGREEMENT	6. LICENSE AGREEMENT In 1995, the Company entered into a license agreement with the Chief Executive Officer of the Company, Thomas J. Shaw, for the exclusive right to manufacture, market, and distribute products utilizing automated retraction technology, which agreement has been amended twice. This technology is the subject of various patents and patent applications owned by Mr. Shaw. The license agreement provides for quarterly payments of a 5% royalty fee on gross sales. Additionally, if the Company sublicenses the technology and the sublicensee’s customers are not known to the Company, then Mr. Shaw shall be entitled to receive from the Company fifty percent (50%) of the royalties actually paid to the Company by such sublicensee. The royalty fee expense is recognized in the period in which it is earned. Royalty fees of $5,476,306; $3,449,822; and $2,944,102 are included in Cost of sales for the years ended December 31, 2020, 2019, and 2018, respectively. Royalties payable under this agreement aggregated $1,973,781 and $921,445 at December 31, 2020, and 2019, respectively. Gross sales upon which royalties are based were $109,526,118; $67,529,783; and $58,882,042; for 2020, 2019, and 2018, respectively.

XML 27 R13.htm IDEA: XBRL DOCUMENT

OTHER ACCRUED LIABILITIES

12 Months Ended

Dec. 31, 2020

OTHER ACCRUED LIABILITIES

OTHER ACCRUED LIABILITIES

7. OTHER ACCRUED LIABILITIES

Other accrued liabilities consist of the following:


	December 31,
	2020		2019
Prepayments from customers	$	1,686,868	$	998,601
Accrued professional fees		331,204		263,757
Current portion – preferred stock repurchase		1,092,282		—
Other accrued expenses		288,550		124,791
Total	$	3,398,904	$	1,387,149

XML 28 R14.htm IDEA: XBRL DOCUMENT

LONG-TERM DEBT

12 Months Ended

Dec. 31, 2020

LONG-TERM DEBT

LONG-TERM DEBT

8. LONG-TERM DEBT

Long-term debt consists of the following:


	December 31,
	2020		2019
Loan from American First National Bank. Maturity date is April 10, 2028. The loan, in the original amount of $4,209,608, provided funding for the expansion of the warehouse, additional office space, and a new Controlled Environment. The loan is secured by the Company’s land and buildings. The interest rate is equal to prime rate plus 0.25%. The interest rate was 5.0% at December 31, 2020.	$	2,378,100	$	2,638,994

Loan from Independent Bank pursuant to the Paycheck Protection Program. Original maturity date is April 17, 2022. The interest rate is equal to 1.0% per annum.		1,363,000		—
		3,741,100		2,638,994

Less: current portion		(1,030,763)		(260,939)
	$	2,710,337	$	2,378,055

The fair value of long-term liabilities, based on Management’s estimates, approximates their reported values.

The aggregate maturities of long-term debt as of December 31, 2020, are as follows:


2021	$	1,030,763
2022		896,210
2023		304,120
2024		319,685
2025		336,488
Thereafter		853,834
	$	3,741,100

XML 29 R15.htm IDEA: XBRL DOCUMENT

OTHER LONG-TERM LIABILITIES

12 Months Ended

Dec. 31, 2020

OTHER LONG-TERM LIABILITIES

OTHER LONG-TERM LIABILITIES

9. OTHER LONG-TERM LIABILITIES

Other long-term liabilities consists of the following:


	December 31,
	2020		2019
Technology Investment Agreement (TIA)		22,444,324		—
Stock repurchase		2,034,373		—
Total	$	24,478,697	$	—

The TIA provides for reimbursement to the Company for the purchase of equipment and supplies related to the expansion of the Company’s domestic production of needles and syringes. Under the TIA, reimbursable amounts will be reflected as a liability until the time its deferred income can be systematically amortized over a period matching the useful life of the purchased assets.

The stock repurchase liability represents the long-term portion, at net present value, of $3,303,330 gross payable by the Company to former preferred shareholders as a result of private stock purchases in 2020 of 320,333 shares of Class B Series IV preferred stock and 25,000 shares of Class B Series V preferred stock. The purchase price is payable in three annual installments of $1,101,110.

XML 30 R16.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES	12 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	10. COMMITMENTS AND CONTINGENCIES On November 7, 2019, the Company filed a lawsuit in the 44th District Court of Dallas County, Texas (No. DC-19-17946) against Locke Lord, LLP and Roy Hardin in connection with their legal representation of the Company in its previous litigation against Becton, Dickinson and Company (“BD”). The Company alleges that the defendants breached their fiduciary duties, committed malpractice, and were negligent in their representation of the Company. The Company seeks actual and exemplary damages, disgorgement, costs, and interest. On October 6, 2020, the Court dismissed Defendants' motion to dismiss, which order was appealed by the Defendants on October 9, 2020 to the Court of Appeals, Fifth District of Texas at Dallas. Oral argument for the appeal has been set for April 7, 2021

XML 31 R17.htm IDEA: XBRL DOCUMENT

INCOME TAXES

12 Months Ended

Dec. 31, 2020

INCOME TAXES

INCOME TAXES

11. INCOME TAXES

The provision (benefit) for income taxes consists of the following:


	For the Years Ended December 31,
	2020		2019		2018
Current tax provision (benefit)
Federal	$	4,431,590	$	—	$	(13,318)
State		2,049,850		7,875		—
Total current provision (benefit)		6,481,440		7,875		(13,318)

Deferred tax provision (benefit)
Federal		(3,428,399)		—		—
State		(1,202,807)		—		—
Total deferred tax provision (benefit)		(4,631,206)		—		—
Total income tax provision (benefit)	$	1,850,234	$	7,875	$	(13,318)

The Company had $23.3 million in tax benefits attributable to net operating losses for federal tax purposes as of December 31, 2019, which were fully utilized as of December 31, 2020. The Company has state net operating losses of $3.6 million as of December 31, 2020 which will begin to expire in 2029. The Company also had credits for alternative minimum taxes (“AMT”) paid of $100 thousand as of December 31, 2019. The alternative minimum tax was repealed with the enactment of the Tax Cuts and Jobs Act. The Company recorded the AMT credit as a tax receivable on its financial statements as of December 31, 2019 rather than as a deferred tax asset, as this amount is a refundable credit. The AMT credit refund receivable at December 31, 2019 was claimed on the Company’s 2019 corporate income tax return and was received in 2020.

Utilization of the state net operating loss carry forwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by state rules that are similar to the Internal Revenue Code of 1986, as amended.

Deferred taxes are provided for those items reported in different periods for income tax and financial reporting purposes. The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are presented below:


	December 31,
	2020		2019
Deferred tax assets
Net operating loss carry forwards	$	198,675	$	5,748,724
Accrued expenses and reserves		824,920		573,382
Employee stock option expense		15,188		75,591
Nonemployee stock option expense		8,515		8,207
Inventories		98,748		110,455
Impairment		—		111,178
Deferred income – TIA contract		5,675,617		—
Unrealized gains/losses		—		30,434
Deferred tax assets		6,821,663		6,657,971
Deferred tax liabilities
Unrealized gains/losses		(508,197)		—
Property, plant, and equipment		(1,682,260)		(1,628,133)
Deferred tax liabilities		(2,190,457)		(1,628,133)
Net deferred assets		4,631,206		5,029,838
Valuation allowance		—		(5,029,838)
Net deferred tax assets	$	4,631,206	$	—

Deferred income tax calculations reflect the effects of temporary differences between the carrying amounts of assets and liabilities and their tax bases, as well as from net operating loss carry forwards, and are stated at the U.S. tax rate of 21%. Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years.

Deferred tax assets are periodically reviewed for realizability. In prior periods, the Company established a valuation allowance for its net deferred tax asset as future taxable income which could not be reasonably assured. The valuation allowance was fully released during the year ended December 31, 2020. The valuation allowance was decreased by $5,029,838 for 2020 and decreased by $1,121,560 for 2019.

Under the Tax Cuts and Jobs Act, net operating losses incurred after December 31, 2017 can only offset 80% of taxable income. However, these net operating losses may be carried forward indefinitely instead of limited to twenty years under previous tax law. Carryback of these losses is no longer permitted.

The CARES Act temporarily removed the 80% of taxable income limitation to allow NOL carryforwards to fully offset income. For tax years beginning before 2021, the Company can take an NOL deduction equal to 100% of taxable income. For tax years beginning after 2021, the Company can take: (1) a 100% deduction of NOLs arising in tax years prior to 2018, and (2) a deduction limited to 80% of modified taxable income for NOLs arising in tax years after 2017.

A reconciliation of income taxes based on the federal statutory rate and the effective income tax rate is summarized as follows:


	December 31,
	2020		2019		2018
Income tax at the federal statutory rate	21.0	%	21.0	%	21.0	%
State tax, net of federal tax	4.2		2.0		3.5
Change in valuation allowance	(19.2)		(35.6)		(24.3)
Permanent differences	(0.6)		—		(0.3)
Return-to-provision and other	1.7		12.9		(0.9)
Tax Reform and Jobs Act tax rate change	—		—		0.1
Effective tax rate	7.1	%	0.3	%	(0.9)	%

The Company files income tax returns in the U.S. federal jurisdiction and in various state and local jurisdictions. The Company’s federal income tax returns for all tax years ended on or after December 31, 2017, remain subject to examination by the Internal Revenue Service. The Company’s state and local income tax returns are subject to examination by the respective state and local authorities over various statutes of limitations, most ranging from three to five years from the date of filing.

XML 32 R18.htm IDEA: XBRL DOCUMENT

DIVIDENDS	12 Months Ended
DIVIDENDS	Dec. 31, 2020
DIVIDENDS
DIVIDENDS	12. DIVIDENDS The Board declared and the Company paid cash dividends to Series I and Series II Class B Preferred Shareholders within one month of the end of each quarter in 2018, 2019, and 2020, resulting in cumulative annual payments of: $49,250, and $171,200 to Series I and Series II preferred shareholders, respectively, in 2018; $48,625, and $171,200 to Series I and Series II preferred shareholders, respectively, in 2019; $48,000, and $168,642 to Series I and Series II preferred shareholders, respectively, in 2020; and one payment of $10,041, and $39,050 to Series I and Series II preferred shareholders, respectively, in 2021.

XML 33 R19.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY	12 Months Ended
STOCKHOLDERS' EQUITY	Dec. 31, 2020
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY	13. STOCKHOLDERS’ EQUITY Preferred Stock The Company is authorized to issue 5,000,000 shares of Preferred Stock Class A with a par value of One Dollar ($1.00) per share; 5,000,000 shares of Preferred Stock Class B with a par value of One Dollar ($1.00) per share; and 5,000,000 shares of Preferred Stock Class C with a par value of One Dollar ($1.00) per share. The Company has one class of Preferred Stock outstanding: Class B Convertible Preferred Stock (“Class B Stock”). The Class B Stock has two series: Series II and Series III. Series I, Series IV, and Series V were cancelled by Board resolution effective March 16,2021. The Class B Series II and III stock had 156,200 and 106,745 shares outstanding, respectively, at December 31, 2020. The remaining 4,737,055 authorized shares have not been assigned a series. Series I Class B Stock There were 0 and 96,000 shares of $1 par value Series I Class B Stock outstanding at December 31, 2020 and 2019 , respectively. Holders of Series I Class B Stock were entitled to receive a cumulative annual dividend of $0.50 per share, payable quarterly if declared by the Board of Directors. The Company paid dividends of $48,000 in 2020 and $48,625 in 2019. At December 31, 2020, no dividends were in arrears. Series I Class B Stock was redeemable at the option of the Company at a price of $7.50 per share, plus all unpaid dividends. Such a redemption took place effective December 31, 2020. Each share of Series I Class B Stock was, at the option of the stockholder, convertible to one share of Common Stock. 81,700 shares of Series I Class B Stock was converted to Common Stock in 2020 and the remaining 14,300 shares were redeemed by the Company as of December 31, 2020 for a total redemption price payable of $107,250. 2,500 shares of Series I Class B Stock were converted into Common Stock in 2019. In the event of voluntary or involuntary dissolution, liquidation, or winding up of the Company, holders of Series I Class B Stock then outstanding would have been entitled to $6.25 per share, plus all unpaid dividends prior to any distributions to holders of Series II Class B Stock, Series III Class B Stock, Series IV Class B Stock, Series V Class B Stock, or Common Stock. Series II Class B Stock There were 156,200 and 171,200 shares of $1 par value Series II Class B Stock outstanding at December 31, 2020 and 2019,respectively. Holders of Series II Class B Stock are entitled to receive a cumulative annual dividend of $1.00 per share, payable quarterly if declared by the Board of Directors. Holders of Series II Class B Stock generally have no voting rights until dividends are in arrears and unpaid for twelve consecutive quarters. In such case, the holders of Series II Class B Stock have the right to elect one-third of the Board of Directors of the Company. The Company paid dividends of $168,642 in 2020 and $171,200 in 2019. At December 31, 2020, no dividends were in arrears. Series II Class B Stock is redeemable at the option of the Company at a price of $15.00 per share plus all unpaid dividends. Each share of Series II Class B Stock may, at the option of the stockholder, be converted to one share of Common Stock. 15,000 shares were converted into Common Stock in 2020. No shares were converted in 2019. In the event of voluntary or involuntary dissolution, liquidation, or winding up of the Company, holders of Series II Class B Stock then outstanding are entitled to $12.50 per share, plus all unpaid dividends, prior to any distributions to holders of Series III Class B Stock or Common Stock. Series III Class B Stock There were 106,745 and 129,245 shares of $1 par value Series III Class B Stock outstanding at December 31, 2020 and 2019. Holders of Series III Class B Stock are entitled to receive a cumulative annual dividend of $1.00 per share, payable quarterly if declared by the Board of Directors. At December 31, 2020, approximately $4,037,000 of dividends which have not been declared were in arrears. Series III Class B Stock is redeemable at the option of the Company at a price of $15.00 per share, plus all unpaid dividends. Each share of Series III Class B Stock may, at the option of the stockholder, be converted to one share of Common Stock. No shares were converted in 2020 or 2019. 22,500 shares were exchanged for Common Stock in private transactions in 2020. Please see Note 19 for a description of private exchange transactions in 2020. In the event of voluntary or involuntary dissolution, liquidation, or winding up of the Company, holders of Series III Class B Stock then outstanding are entitled to $12.50 per share, plus all unpaid dividends, after distribution obligations to Series II Class B Stock have been satisfied and prior to any distributions to holders of Common Stock. Series IV Class B Stock There were 0 and 342,500 shares of $1 par value Series IV Class B Stock outstanding at December 31, 2020 and 2019,respectively. Holders of Series IV Class B Stock were entitled to receive a cumulative annual dividend of $1.00 per share, payable quarterly, if declared by the Board of Directors. At December 31, 2020, approximately $101,000 of dividends which have not been declared were in arrears. Series IV Class B Stock was redeemable at the option of the Company at a price of $11.00 per share plus all unpaid dividends. Each share of Series IV Class B Stock was, at the option of the stockholder any time, convertible into one share of Common Stock. No shares of Series IV Class B Stock were converted into Common Stock in 2020 or 2019. 342,500 shares were exchanged for Common Stock in private transactions in 2020. Please see Note 19 for a description of private exchange transactions in 2020. In the event of voluntary or involuntary liquidation, dissolution, or winding up of the Company, holders of Series IV Class B Stock then outstanding would have been entitled to receive liquidating distributions of $11.00 per share, plus all unpaid dividends after distribution obligations to Series I Class B Stock, Series II Class B Stock, and Series III Class B Stock have been satisfied and prior to any distribution to holders of Series V Class B Stock or Common Stock. Series V Class B Stock There were 0 and 34,000 shares of $1 par value Series V Class B Stock outstanding at December 31, 2020 and 2019, respectively. Holders of Series V Class B Stock were entitled to receive a cumulative annual dividend of $0.32 per share, payable quarterly, if declared by the Board of Directors. At December 31, 2020, approximately $830,000 of dividends which have not been declared were in arrears. Series V Class B Stock was redeemable at the option of the Company at a price of $4.40 per share plus all unpaid dividends. Each share of Series V Class B Stock was, at the option of the stockholder any time, convertible into Common Stock. 0 and 6,000 shares of Series V Class B Stock were converted into Common Stock in 2020 and 2019, respectively. 34,000 shares were exchanged for Common Stock in private transactions in 2020. Please see Note 19 for a description of private exchange transactions in 2020. In the event of voluntary or involuntary liquidation, dissolution, or winding up of the Company, holders of Series V Class B Stock then outstanding would have been entitled to receive liquidating distributions of $4.40 per share, plus all unpaid dividends after distribution obligations to Series I Class B Stock, Series II Class B Stock, Series III Class B Stock, and Series IV Class B Stock have been satisfied and prior to any distribution to the holders of the Common Stock. Common stock The Company is authorized to issue 100,000,000 shares of no par value Common Stock, of which 33,957,204 and 32,674,954 shares were outstanding at December 31, 2020 and 2019, respectively. Additionally, as of December 31, 2020, a total of 462,395 shares of Common Stock were issuable upon the conversion of Preferred Stock and the exercise of stock options.

XML 34 R20.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS	12 Months Ended
RELATED PARTY TRANSACTIONS	Dec. 31, 2020
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	14. RELATED PARTY TRANSACTIONS The Company has a license agreement with the Chief Executive Officer of the Company. See Note 6.

XML 35 R21.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS

12 Months Ended

Dec. 31, 2020

STOCK OPTIONS

STOCK OPTIONS

15. STOCK OPTIONS

Stock options

Options for the purchase of 3,649,508 shares of Common Stock have been issued under the 2008 Stock Option Plan. Options for the purchase of 199,450 shares under the 2008 Stock Option Plan were outstanding as of December 31, 2020. No shares are available for future issuance under the 2008 Stock Option Plan, which expired July 25, 2018.

The Compensation and Benefits Committee administered the Company’s stock option plan prior to its termination.

Stock option exercises

Stock options were exercised by the Company’s employees and directors during 2020, and, consequently, a total of 431,550 shares of Common Stock were issued for an aggregate payment to the Company of $922,512 to exercise such options.

Director, officer, and employee options

A summary of Director, officer, and employee options granted and outstanding under the 2008 Stock Option Plan is presented below:


	Years Ended December 31,
	2020			2019			2018
		Weighted			Weighted			Weighted
		Average			Average			Average
		Exercise			Exercise			Exercise
	Shares	Price		Shares	Price		Shares	Price
Outstanding at beginning of period	639,300	$	2.12	1,300,303	$	1.57	1,805,519	$	1.51
Granted	—	$	—	—	$	—	—	$	—
Exercised	(431,550)	$	(2.14)	—	$	—	—	$	—
Forfeited	(8,300)	$	(2.75)	(661,003)	$	(1.05)	(505,216)	$	(1.36)

Outstanding at end of period	199,450	$	2.05	639,300	$	2.12	1,300,303	$	1.57

Exercisable at end of period	199,450	$	2.05	639,300	$	2.12	1,300,303	$	1.57

No options were issued in 2020, 2019, or 2018 to employees or non-employee directors.

The following table summarizes information about Director, officer, and employee options outstanding under the stock option plan at December 31, 2020:


			Weighted Average
Exercise Prices		Shares Outstanding	Remaining Contractual Life	Shares Exercisable
$	1.05	82,500	5.99	82,500
$	2.75	116,950	5.70	116,950

Non-employee options

A summary of options outstanding and held by non-employees is as follows:


	Years Ended December 31,
	2020			2019			2018
		Weighted			Weighted			Weighted
		Average			Average			Average
		Exercise			Exercise			Exercise
	Shares	Price		Shares	Price		Shares	Price

Outstanding at beginning of period	—	$	—	57,500	$	0.81	57,500	$	0.81
Granted	—	$	—	—	$	—	—	$	—
Exercised	—	$	—	—	$	—	—	$	—
Forfeited	—	$	—	(57,500)	$	(0.81)	—	$	—

Outstanding at end of period	—	$	—	—	$	—	57,500	$	0.81

Exercisable at end of period	—	$	—	—	$	—	57,500	$	0.81

The Company recorded no stock-based compensation expense in 2018, 2019, or 2020. At December 31, 2020, there were 199,450 stock options with exercise prices lower than the closing market price. The intrinsic value of these options at December 31, 2020 was $1,733,856.

Options Pricing Models – Assumptions

The expected life is based on the Company’s historical experience with option exercise trends. The assumptions for expected volatility are based on a calculation of volatility over the five-years preceding the grant date. Risk-free interest rates are set using grant-date U.S. Treasury yield curves. In its calculations, the Company assumed no dividends. The Company elected a policy to account for forfeitures as they occur, rather than on an estimated basis.

XML 36 R22.htm IDEA: XBRL DOCUMENT

401(k) PLAN	12 Months Ended
401(k) PLAN	Dec. 31, 2020
401(k) PLAN
401(k) PLAN	16. 401(k) PLAN The Company implemented an employee savings and retirement plan (the “401(k) Plan”) in 2005 that is intended to be a tax-qualified plan covering substantially all employees. The 401(k) Plan is available to all employees on the first day of the month after 90 days of service. Under the terms of the 401(k) Plan, employees may elect to contribute up to 88% of their compensation, or the statutory prescribed limit, if less. The Company may, at its discretion, match employee contributions. For 2020, 2019, and 2018, the Company matched each participant’s elective deferrals up to 2% of the participant’s compensation for the pay period. The total match was $162,008; $117,917; and $145,146 in 2020, 2019, and 2018, respectively.

XML 37 R23.htm IDEA: XBRL DOCUMENT

BUSINESS SEGMENT

12 Months Ended

Dec. 31, 2020

BUSINESS SEGMENT

BUSINESS SEGMENT

17. BUSINESS SEGMENT

The following is a summary of the Company’s sales and long-lived assets by geography:


	2020		2019		2018
U.S. sales	$	73,803,806	$	31,897,924	$	28,646,574
North and South America sales (excluding U.S.)		6,893,150		8,248,990		3,597,444
Other international sales		1,165,497		1,650,265		1,030,684
Total sales	$	81,862,453	$	41,797,179	$	33,274,702

Long-lived assets		2020		2019
U.S.	$	30,751,259	$	10,542,688
International	$	65,245	$	89,369

The Company does not operate in separate reportable segments. Shipments to international customers generally require a prepayment either by wire transfer or an irrevocable confirmed letter of credit. The Company does extend credit to international customers on some occasions depending upon certain criteria, including, but not limited to, the credit worthiness of the customer, the stability of the country, banking restrictions, and the size of the order. All transactions are in U.S. currency.

XML 38 R24.htm IDEA: XBRL DOCUMENT

LEASES

12 Months Ended

Dec. 31, 2020

LEASES

LEASES

18. LEASES

The Company has operating leases for a warehouse and equipment. The leases have a remaining lease term of less than one year. The Company currently has no finance leases. The ROU asset is determined based on the lease liability adjusted for lease incentives received. Lease expense is recognized on a straight-line basis over the lease term. The leases may include various expenses incidental to the use of the property, such as common area maintenance, property taxes and insurance. These costs are separate from the minimum rent payment and are not considered in the determination of the lease liability and ROU asset. The Company has not noted any material instances in its leases where these costs were combined with the minimum rent payment and has therefore elected the policy to not separate lease from non-lease components if they are combined with the minimum rent payment. The option periods are not included in the determination of the lease liability and right-of-use asset as the Company is not reasonably certain if it will extend at the time of lease commencement.

The operating lease cost component of the lease expense was $103,312 and $80,648 for the years ended December 31, 2020 and 2019, respectively. The cash paid for amounts included in the measurement of lease liabilities as a component of cash flows related to leases was $106,101 and $80,648 for the years ended December 31, 2020 and 2019, respectively.

Assets and liabilities associated with these leases included in the Balance Sheets are as follows:


	December 31,
	2020		2019
OPERATING LEASES
Other assets	$	38,892	$	82,359
Other accrued liabilities	$	38,892	$	82,359
Other long-term liabilities		—		—
Total operating lease liabilities	$	38,892	$	82,359

XML 39 R25.htm IDEA: XBRL DOCUMENT

PRIVATE EXCHANGES AND REDEMPTION	12 Months Ended
PRIVATE EXCHANGES AND REDEMPTION	Dec. 31, 2020
PRIVATE EXCHANGES AND REDEMPTION
PRIVATE EXCHANGES AND REDEMPTION	19. PRIVATE EXCHANGES AND REDEMPTION Private Exchanges of Preferred Stock for Common Stock In 2020, the Company entered into several agreements with shareholders to purchase its outstanding Class B Convertible Preferred Stock. The consideration for these purchases consisted of both cash and Common Stock. In addition, in each such transaction, the preferred shareholder counterparty waived their rights to unpaid dividends in arrears. In total, 22,500 shares of Series III Class B Convertible Preferred Stock, 342,500 shares of Series IV Class B Convertible Preferred Stock, and 34,000 shares of Series V Class B Convertible Preferred Stock were purchased by the Company. The aggregate cash consideration equaled $3,786,000, of which $482,670 was paid in 2020 with the rest payable over a three-year period beginning February 2021. The aggregate stock consideration was 754,000 shares of Common Stock. As a result of the transactions, $7,642,049 in unpaid dividends in arrears were waived, as measured from the effective date of each transaction. Redemption of Class B Series I Preferred Stock The Company caused a redemption of its Class B Series I Preferred Stock on December 31, 2020 pursuant to the terms of the Certificate of Designation for such series of preferred stock which required a redemption price of $7.50 per share. Pursuant to such redemption, all shares of the Class B Series I Preferred Stock existing on December 31, 2020 (14,300 shares) were cancelled.

XML 40 R26.htm IDEA: XBRL DOCUMENT

PAYCHECK PROTECTION PROGRAM LOAN

12 Months Ended

Dec. 31, 2020

PAYCHECK PROTECTION PROGRAM LOAN

PAYCHECK PROTECTION PROGRAM LOAN

20. PAYCHECK PROTECTION PROGRAM LOAN

On April 17, 2020, the Company entered into a promissory note in the principal amount of $1,363,000 (the "PPP Loan") in favor of Independent Bank pursuant to the Paycheck Protection Program (the "PPP") of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"), administered by the U.S. Small Business Administration ("SBA"). The PPP Loan's original maturity date is April 17, 2022 and bears interest at a rate of 1.0% per annum. The PPP Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. The PPP Loan is unsecured and is a non-recourse obligation. The Company has requested forgiveness for the PPP Loan but cannot be assured that such request will be granted.

Assuming the PPP Loan is not forgiven, the Company's obligations thereunder are as follows at December 31, 2020:


2021	$	755,907
2022		607,093
	$	1,363,000

XML 41 R27.htm IDEA: XBRL DOCUMENT

COVID-19	12 Months Ended
COVID-19	Dec. 31, 2020
COVID-19
COVID-19	21. COVID-19 To date, the Company's manufacturing facility in Little Elm, Texas has continued to operate due to its status as an essential business. As a result of the COVID-19 pandemic, the Company has implemented certain safety precautions at its facility to reduce the risk of the potential spread of the novel coronavirus. The Company has implemented arrangements to reduce the number of office staff employees working on-site at the production facility, as well as instituting personal distancing policies and monitoring of essential production staff to minimize the risk of infection. The Company continues to monitor the evolving situation and will work to further mitigate risks to staff and to customers. The Company is continuing to evaluate the ever-changing circumstances surrounding this pandemic as it relates to its ability to continue to source materials and products, maintain a workforce, and operate its business effectively and efficiently. Despite the global disruption of the coronavirus pandemic, the Company has not experienced a significant disruption to its supply chain. During 2020, the Company has experienced an increase in demand for its products and has been able to meet such demand with increased volumes despite the pandemic. The Company is unable to predict with certainty its ability to maintain its current operational functionality.

XML 42 R28.htm IDEA: XBRL DOCUMENT

TECHNOLOGY INVESTMENT AGREEMENT	12 Months Ended
TECHNOLOGY INVESTMENT AGREEMENT	Dec. 31, 2020
TECHNOLOGY INVESTMENT AGREEMENT
TECHNOLOGY INVESTMENT AGREEMENT	22. TECHNOLOGY INVESTMENT AGREEMENT Effective July 1, 2020, the Company entered into the TIA with the U.S. government. The principal purpose of the TIA is to fund the expansion of the Company's manufacturing capacity for hypodermic safety needles and corresponding syringes in response to the worldwide COVID-19 global pandemic. The award is an expenditure-type TIA, whereby the U.S. government will make payments to the Company for the Company's expenditures for equipment and supplies in carrying out the expansion of the Company's domestic production. The Company's contributions under the terms of the TIA to enhance domestic capacity of pandemic-essential technology include providing facilities, technical expertise, labor, and maintenance of the TIA-funded equipment for a ten-year term. As of December 31, 2020, the Company has negotiated contracts for the purchase of automated assembly equipment, molds, and molding equipment, as well as portions of auxiliary equipment, for approximately $41.5 million. As of March 2021, the Company has substantially completed construction of expanded facilities consisting of approximately 27,800 square feet of additional controlled environment within existing properties and is expected to complete approximately 55,000 square feet of new warehouse space within the second quarter of 2021. The estimated cost of the controlled environment within existing properties is $6.4 million. The increase from the original $6 million estimate is due to change orders and an expedited completion date in order to receive certain manufacturing equipment at an earlier date. The new warehouse space is estimated to cost $5.8 million. The cost of the controlled environment will be funded by the U.S. government under the TIA, while the cost of the new warehouse will be funded by the Company.

XML 43 R29.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	23. SUBSEQUENT EVENTS The Department of Health and Human Services entered into a contract with the Company on February 12, 2021 to supply low dead space safety syringes. The base price for the contract and purchase order is $54,217,800 for the five-month base period of performance from February 15, 2021 to July 14, 2021. Such price includes both the fixed price for the products as well as cost reimbursement for freight. The terms of the contract allow for extensions at the option of the U.S. government for up to seven additional one-month periods. If all option periods are exercised, the value of the contract could increase by an additional $92,772,680, including the price of the products and freight reimbursement. On March 16, 2021, the Company approved the 2021 Stock Option Plan (the “Plan”) and set aside and reserved 2,000,000 shares of Common Stock for issuance pursuant to the Plan. The Plan is subject to shareholder approval at the May 11, 2021 shareholder meeting. The Plan provides for the granting of incentive stock options and non-qualified stock options at a price equal to at least 100% of the fair market value of the Company’s Common Stock as of the date of grant. Participants in the Plan may include employees, consultants, and non-employee Directors. On March 16, 2021, the Company approved option grants to purchase 1,000,000, 250,000, and 100,000 shares of Common Stock to the Company’s chief executive officer, general counsel, and chief financial officer, respectively. These shares will vest in their entirety three years from the grant date. No award shall be exercisable unless and until the Plan has been approved by the shareholders.

XML 44 R30.htm IDEA: XBRL DOCUMENT

Schedule II-Schedule of Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2019

Schedule II - Schedule of Valuation and Qualifying Accounts

Schedule II - Schedule of Valuation and Qualifying Accounts

Item 15. Exhibits, Financial Statement Schedules.

(a) (1) All financial statements: See Retractable Technologies, Inc. Index to Financial Statements on Page F-2.

(2) Those financial statement schedules required to be filed by Item 8 of this form, and by paragraph (b) below. Schedule II-Schedule of Valuation and Qualifying Accounts for the years ended December 31, 2020, 2019, and 2018:


	Balance at
	beginning						Balance at
	of period		Additions		Deductions		end of period
Provision for Inventories
Fiscal year ended 2018	$	594,939	$	—	$	297,731	$	297,208
Fiscal year ended 2019	$	297,208	$	—	$	—	$	297,208
Fiscal year ended 2020	$	297,208	$	—	$	—	$	297,208

Provision for Accounts Receivable
Fiscal year ended 2018	$	101,872	$	47,793	$	—	$	149,665
Fiscal year ended 2019	$	149,665	$	—	$	3,283	$	146,382
Fiscal year ended 2020	$	146,382	$	125,000	$	65,560	$	205,822

Deferred Tax Valuation
Fiscal year ended 2018	$	5,825,954	$	325,444	$	—	$	6,151,398
Fiscal year ended 2019	$	6,151,398	$	—	$	1,121,560	$	5,029,838
Fiscal year ended 2020	$	5,029,838	$	—	$	5,029,838	$	—

Provision for Rebates				(A)		(B)		(C)
Fiscal year ended 2018	$	4,794,193	$	24,372,111	$	24,579,457	$	4,586,847
Fiscal year ended 2019	$	4,586,847	$	24,212,830	$	24,526,108	$	4,273,569
Fiscal year ended 2020	$	4,273,569	$	26,104,612	$	26,566,256	$	3,811,925

(A)

Represents estimated rebates deducted from gross revenues.

(B)

Represents rebates credited to the distributor and charge offs against the allowance.

(C)

Includes $3,435,352; $3,586,726; and $3,896,341 in Accounts payable for 2020, 2019, and 2018, respectively.

XML 45 R31.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2020

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting estimates

Cash and cash equivalents

For purposes of reporting cash flows, cash and cash equivalents include cash, money market accounts, and investments with original maturities of three months or less.

Accounts receivable

The Company records an allowance for estimated returns as a reduction to Accounts receivable and Gross sales. Historically, returns have been insignificant.

Inventories

Investments in debt and equity securities

Property, plant, and equipment


Production equipment		3 to 13 years
Office furniture and equipment		3 to 10 years
Buildings		39 years
Building improvements		15 years

Long-lived assets

Fair value measurements

Financial instruments

Concentration risks

The following table reflects our significant customers in 2020, 2019, and 2018:


	Years Ended December 31,
	2020			2019			2018
Number of significant customers		2			3			2
Aggregate dollar amount of net sales to significant customers	$	41.6 million		$	19.0 million		$	13.1 million
Percentage of net sales to significant customers		50.6	%		45.6	%		39.2	%

The Company increased its allowance for doubtful accounts by approximately $125 thousand in 2020.

Revenue recognition

The Company’s international distribution agreements generally do not provide for any returns.

Disaggregated information of revenue recognized from contracts with customers and licensing fees recognized are as follows:


	For the year ended December 31, 2020:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales (excluding HHS Order)	$	30,446,858	$	2,116,108	$	9,542,122	$	64,375	$	42,169,463
HHS Order sales to U.S. government		31,634,343		—		—		—		31,634,343
North and South America sales (excluding U.S.)		5,733,116		8,450		86,816		1,064,768		6,893,150
Other international sales		917,478		239,329		235		8,455		1,165,497
Total	$	68,731,795	$	2,363,887	$	9,629,173	$	1,137,598	$	81,862,453


	For the year ended December 31, 2019:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales	$	26,722,414	$	2,130,767	$	2,970,374	$	74,369	$	31,897,924
North and South America sales (excluding U.S.)		7,863,796		6,313		7,996		370,885		8,248,990
Other international sales		1,052,217		578,617		635		18,796		1,650,265
Total	$	35,638,427	$	2,715,697	$	2,979,005	$	464,050	$	41,797,179


	For the year ended December 31, 2018:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales	$	23,803,483	$	1,365,936	$	3,401,389	$	75,766	$	28,646,574
North and South America sales (excluding U.S.)		3,521,823		8,805		252		66,564		3,597,444
Other international sales		940,740		48,101		11,768		30,075		1,030,684
Total	$	28,266,046	$	1,422,842	$	3,413,409	$	172,405	$	33,274,702

Income taxes

Earnings per share


	Years Ended December 31,
	2020		2019		2018
Net income (loss)	$	24,223,013	$	3,148,234	$	(1,339,943)
Preferred stock dividend requirements		(573,868)		(702,618)		(704,996)
Deemed contribution on extinguishment of preferred stock		2,975,708		—		—
Income (loss) applicable to common stockholders	$	26,624,853	$	2,445,616	$	(2,044,939)

Weighted Average common shares outstanding		33,169,307		32,672,475		32,666,454
Weighted Average common and common equivalent shares outstanding - assuming dilution		33,300,654		32,672,475		32,666,454
Basic earnings (loss) per share	$	0.80	$	0.07	$	(0.06)
Diluted earnings (loss) per share	$	0.80	$	0.07	$	(0.06)

The Company has determined to apply this guidance to its accounting treatment of the preferred stock transactions described in Note 19.

Shipping and handling costs

The Company classifies shipping and handling costs as part of Cost of sales in the Statements of Operations.

Self-insured employee benefit costs

Research and development costs

Research and development costs are expensed as incurred.

Share-based compensation

Insurance Proceeds

Leases

Technology Investment Agreement (TIA)

Recently Adopted Pronouncements and Recently Issued Pronouncements

Recently Adopted Pronouncements

Recently Issued Pronouncements

XML 46 R32.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2020

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of estimated useful lives of property, plant and equipment


Production equipment		3 to 13 years
Office furniture and equipment		3 to 10 years
Buildings		39 years
Building improvements		15 years

Schedule of significant customers


	Years Ended December 31,
	2020			2019			2018
Number of significant customers		2			3			2
Aggregate dollar amount of net sales to significant customers	$	41.6 million		$	19.0 million		$	13.1 million
Percentage of net sales to significant customers		50.6	%		45.6	%		39.2	%

Schedule of disaggregated information of revenue recognized from contracts with customers and licensing fees


	For the year ended December 31, 2020:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales (excluding HHS Order)	$	30,446,858	$	2,116,108	$	9,542,122	$	64,375	$	42,169,463
HHS Order sales to U.S. government		31,634,343		—		—		—		31,634,343
North and South America sales (excluding U.S.)		5,733,116		8,450		86,816		1,064,768		6,893,150
Other international sales		917,478		239,329		235		8,455		1,165,497
Total	$	68,731,795	$	2,363,887	$	9,629,173	$	1,137,598	$	81,862,453


	For the year ended December 31, 2019:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales	$	26,722,414	$	2,130,767	$	2,970,374	$	74,369	$	31,897,924
North and South America sales (excluding U.S.)		7,863,796		6,313		7,996		370,885		8,248,990
Other international sales		1,052,217		578,617		635		18,796		1,650,265
Total	$	35,638,427	$	2,715,697	$	2,979,005	$	464,050	$	41,797,179


	For the year ended December 31, 2018:
			Blood						Total
			Collection		EasyPoint®		Other		Product
Geographic Segment	Syringes		Products		Needles		Products		Sales
U.S. sales	$	23,803,483	$	1,365,936	$	3,401,389	$	75,766	$	28,646,574
North and South America sales (excluding U.S.)		3,521,823		8,805		252		66,564		3,597,444
Other international sales		940,740		48,101		11,768		30,075		1,030,684
Total	$	28,266,046	$	1,422,842	$	3,413,409	$	172,405	$	33,274,702

Schedule of earnings per share


	Years Ended December 31,
	2020		2019		2018
Net income (loss)	$	24,223,013	$	3,148,234	$	(1,339,943)
Preferred stock dividend requirements		(573,868)		(702,618)		(704,996)
Deemed contribution on extinguishment of preferred stock		2,975,708		—		—
Income (loss) applicable to common stockholders	$	26,624,853	$	2,445,616	$	(2,044,939)

Weighted Average common shares outstanding		33,169,307		32,672,475		32,666,454
Weighted Average common and common equivalent shares outstanding - assuming dilution		33,300,654		32,672,475		32,666,454
Basic earnings (loss) per share	$	0.80	$	0.07	$	(0.06)
Diluted earnings (loss) per share	$	0.80	$	0.07	$	(0.06)

XML 47 R33.htm IDEA: XBRL DOCUMENT

INVENTORIES (Tables)

12 Months Ended

Dec. 31, 2020

INVENTORIES

Schedule of inventories


	December 31,
	2020		2019
Raw materials	$	1,358,552	$	1,254,313
Finished goods		9,173,302		6,493,487
		10,531,854		7,747,800
Inventory reserve		(297,208)		(297,208)
	$	10,234,646	$	7,450,592

XML 48 R34.htm IDEA: XBRL DOCUMENT

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)

12 Months Ended

Dec. 31, 2020

FAIR VALUE OF FINANCIAL INSTRUMENTS

Summary of value of assets designated as investments in debt and equity securities


	December 31, 2020
	Level 1		Level 2		Level 3		Total
Equity securities	$	3,990,533	$	—	$	—	$	3,990,533
Mutual funds and exchange traded funds		4,013,956		—		—		4,013,956
Certificates of deposit		—		77,344		—		77,344
	$	8,004,489	$	77,344	$	—	$	8,081,833


	December 31, 2019
	Level 1		Level 2		Level 3		Total
Mutual funds and exchange traded funds	$	6,708,746	$	—	$	—	$	6,708,746
Certificates of deposit		—		1,062,914		—		1,062,914
	$	6,708,746	$	1,062,914	$	—	$	7,771,660

Schedule of unrealized gains (losses) on investments in equity securities


	December 31, 2020
			Gross Unrealized				Aggregate
	Cost		Gains		Losses		Fair Value
Equity securities	$	2,098,144	$	1,892,389	$	—	$	3,990,533
Mutual funds and exchange traded funds		3,909,364		104,592		—		4,013,956
Certificates of deposit		75,000		2,344		—		77,344
	$	6,082,508	$	1,999,325	$	—	$	8,081,833


	December 31, 2019
			Gross Unrealized				Aggregate
	Cost		Gains		Losses		Fair Value
Mutual funds and exchange traded funds	$	6,592,345	$	116,401	$	—	$	6,708,746
Certificates of deposit		1,050,000		12,914		—		1,062,914
	$	7,642,345	$	129,315	$	—	$	7,771,660

XML 49 R35.htm IDEA: XBRL DOCUMENT

PROPERTY, PLANT, AND EQUIPMENT (Tables)

12 Months Ended

Dec. 31, 2020

PROPERTY, PLANT, AND EQUIPMENT

Schedule of property, plant, and equipment


	December 31,
	2020		2019

Land	$	261,893	$	261,893
Buildings and building improvements		11,593,952		11,566,115
Production equipment		20,290,331		19,903,236
Office furniture and equipment		3,630,455		3,527,577
Construction in progress		21,365,915		765,176
		57,142,546		36,023,997
Accumulated depreciation		(26,326,042)		(25,391,940)
	$	30,816,504	$	10,632,057

XML 50 R36.htm IDEA: XBRL DOCUMENT

OTHER ACCRUED LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2020

OTHER ACCRUED LIABILITIES

Schedule of other accrued liabilities


	December 31,
	2020		2019
Prepayments from customers	$	1,686,868	$	998,601
Accrued professional fees		331,204		263,757
Current portion – preferred stock repurchase		1,092,282		—
Other accrued expenses		288,550		124,791
Total	$	3,398,904	$	1,387,149

XML 51 R37.htm IDEA: XBRL DOCUMENT

LONG-TERM DEBT (Tables)

12 Months Ended

Dec. 31, 2020

LONG-TERM DEBT

Schedule of long-term debt


	December 31,
	2020		2019
Loan from American First National Bank. Maturity date is April 10, 2028. The loan, in the original amount of $4,209,608, provided funding for the expansion of the warehouse, additional office space, and a new Controlled Environment. The loan is secured by the Company’s land and buildings. The interest rate is equal to prime rate plus 0.25%. The interest rate was 5.0% at December 31, 2020.	$	2,378,100	$	2,638,994

Loan from Independent Bank pursuant to the Paycheck Protection Program. Original maturity date is April 17, 2022. The interest rate is equal to 1.0% per annum.		1,363,000		—
		3,741,100		2,638,994

Less: current portion		(1,030,763)		(260,939)
	$	2,710,337	$	2,378,055

Schedule of future payments of long-term debt

The aggregate maturities of long-term debt as of December 31, 2020, are as follows:


2021	$	1,030,763
2022		896,210
2023		304,120
2024		319,685
2025		336,488
Thereafter		853,834
	$	3,741,100

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

XML 52 R38.htm IDEA: XBRL DOCUMENT

OTHER LONG-TERM LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2020

OTHER LONG-TERM LIABILITIES

Schedule of other long-term liabilities


	December 31,
	2020		2019
Technology Investment Agreement (TIA)		22,444,324		—
Stock repurchase		2,034,373		—
Total	$	24,478,697	$	—

XML 53 R39.htm IDEA: XBRL DOCUMENT

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2020

INCOME TAXES

Schedule of provision (benefit) for income taxes


	For the Years Ended December 31,
	2020		2019		2018
Current tax provision (benefit)
Federal	$	4,431,590	$	—	$	(13,318)
State		2,049,850		7,875		—
Total current provision (benefit)		6,481,440		7,875		(13,318)

Deferred tax provision (benefit)
Federal		(3,428,399)		—		—
State		(1,202,807)		—		—
Total deferred tax provision (benefit)		(4,631,206)		—		—
Total income tax provision (benefit)	$	1,850,234	$	7,875	$	(13,318)

Schedule of tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities


	December 31,
	2020		2019
Deferred tax assets
Net operating loss carry forwards	$	198,675	$	5,748,724
Accrued expenses and reserves		824,920		573,382
Employee stock option expense		15,188		75,591
Nonemployee stock option expense		8,515		8,207
Inventories		98,748		110,455
Impairment		—		111,178
Deferred income – TIA contract		5,675,617		—
Unrealized gains/losses		—		30,434
Deferred tax assets		6,821,663		6,657,971
Deferred tax liabilities
Unrealized gains/losses		(508,197)		—
Property, plant, and equipment		(1,682,260)		(1,628,133)
Deferred tax liabilities		(2,190,457)		(1,628,133)
Net deferred assets		4,631,206		5,029,838
Valuation allowance		—		(5,029,838)
Net deferred tax assets	$	4,631,206	$	—

Schedule of reconciliation of income taxes based on the federal statutory rate and the effective income tax rate


	December 31,
	2020		2019		2018
Income tax at the federal statutory rate	21.0	%	21.0	%	21.0	%
State tax, net of federal tax	4.2		2.0		3.5
Change in valuation allowance	(19.2)		(35.6)		(24.3)
Permanent differences	(0.6)		—		(0.3)
Return-to-provision and other	1.7		12.9		(0.9)
Tax Reform and Jobs Act tax rate change	—		—		0.1
Effective tax rate	7.1	%	0.3	%	(0.9)	%

XML 54 R40.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS (Tables)

12 Months Ended

Dec. 31, 2020

Director, officer, and employee

STOCK OPTIONS

Summary of options outstanding


	Years Ended December 31,
	2020			2019			2018
		Weighted			Weighted			Weighted
		Average			Average			Average
		Exercise			Exercise			Exercise
	Shares	Price		Shares	Price		Shares	Price
Outstanding at beginning of period	639,300	$	2.12	1,300,303	$	1.57	1,805,519	$	1.51
Granted	—	$	—	—	$	—	—	$	—
Exercised	(431,550)	$	(2.14)	—	$	—	—	$	—
Forfeited	(8,300)	$	(2.75)	(661,003)	$	(1.05)	(505,216)	$	(1.36)

Outstanding at end of period	199,450	$	2.05	639,300	$	2.12	1,300,303	$	1.57

Exercisable at end of period	199,450	$	2.05	639,300	$	2.12	1,300,303	$	1.57

Schedule of information about stock options by range of exercise prices


			Weighted Average
Exercise Prices		Shares Outstanding	Remaining Contractual Life	Shares Exercisable
$	1.05	82,500	5.99	82,500
$	2.75	116,950	5.70	116,950

Non Employees

STOCK OPTIONS

Summary of options outstanding


	Years Ended December 31,
	2020			2019			2018
		Weighted			Weighted			Weighted
		Average			Average			Average
		Exercise			Exercise			Exercise
	Shares	Price		Shares	Price		Shares	Price

Outstanding at beginning of period	—	$	—	57,500	$	0.81	57,500	$	0.81
Granted	—	$	—	—	$	—	—	$	—
Exercised	—	$	—	—	$	—	—	$	—
Forfeited	—	$	—	(57,500)	$	(0.81)	—	$	—

Outstanding at end of period	—	$	—	—	$	—	57,500	$	0.81

Exercisable at end of period	—	$	—	—	$	—	57,500	$	0.81

XML 55 R41.htm IDEA: XBRL DOCUMENT

BUSINESS SEGMENT (Tables)

12 Months Ended

Dec. 31, 2020

BUSINESS SEGMENT

Schedule of company's sales and long-lived assets by geography


	2020		2019		2018
U.S. sales	$	73,803,806	$	31,897,924	$	28,646,574
North and South America sales (excluding U.S.)		6,893,150		8,248,990		3,597,444
Other international sales		1,165,497		1,650,265		1,030,684
Total sales	$	81,862,453	$	41,797,179	$	33,274,702

Long-lived assets		2020		2019
U.S.	$	30,751,259	$	10,542,688
International	$	65,245	$	89,369

XML 56 R42.htm IDEA: XBRL DOCUMENT

LEASES (Tables)

12 Months Ended

Dec. 31, 2020

LEASES

Schedule of assets and liabilities relating to leases included in the Condensed Balance Sheets

Assets and liabilities associated with these leases included in the Balance Sheets are as follows:


	December 31,
	2020		2019
OPERATING LEASES
Other assets	$	38,892	$	82,359
Other accrued liabilities	$	38,892	$	82,359
Other long-term liabilities		—		—
Total operating lease liabilities	$	38,892	$	82,359

XML 57 R43.htm IDEA: XBRL DOCUMENT

PAYCHECK PROTECTION PROGRAM LOAN (Tables)

12 Months Ended

Dec. 31, 2020

PAYCHECK PROTECTION PROGRAM LOAN

Schedule of future payments of long term debt


2021	$	755,907
2022		607,093
	$	1,363,000

XML 58 R44.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts receivable (Details)	12 Months Ended
	Dec. 31, 2020 customer
Accounts receivable
Number of products consigned to customers	0

XML 59 R45.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, plant and equipment (Details)	12 Months Ended
	Dec. 31, 2020
Production equipment \| Minimum
Property, plant, and equipment
Useful lives (in years)	3 years
Production equipment \| Maximum
Property, plant, and equipment
Useful lives (in years)	13 years
Office furniture and equipment \| Minimum
Property, plant, and equipment
Useful lives (in years)	3 years
Office furniture and equipment \| Maximum
Property, plant, and equipment
Useful lives (in years)	10 years
Buildings
Property, plant, and equipment
Useful lives (in years)	39 years
Building Improvements
Property, plant, and equipment
Useful lives (in years)	15 years

XML 60 R46.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration risks (Details)	12 Months Ended
	Dec. 31, 2020 USD ($) customer	Dec. 31, 2019 USD ($) customer	Dec. 31, 2018 USD ($) customer
Concentration risks
Aggregate dollar amount of net sales to significant customers	$ 81,862,453	$ 41,797,179	$ 33,274,702
Allowance for doubtful accounts	$ (125,000)
Customer Concentration Risk
Concentration risks
Number of significant customers \| customer	2	3	2
Aggregate dollar amount of net sales to significant customers	$ 41,600,000	$ 19,000,000	$ 13,100,000
Percentage of net sales to significant customers	50.60%	45.60%	39.20%
Supplier Concentration Risk
Concentration risks
Percentage of net sales to significant customers	85.20%	82.60%	85.30%
Department of health and human
Concentration risks
Aggregate dollar amount of net sales to significant customers	$ 31,600,000
Contract receivables	$ 83,800,000

XML 61 R47.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue recognition (Details)	12 Months Ended
	Dec. 31, 2020 USD ($) item	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
Revenue recognition
Estimated contractual allowance	$ 3,435,352	$ 3,586,726
Period for return of incorrect shipments	10 days
Number of times overstocking returns are limited \| item	2
Period for return of product due to overstock	12 months
Maximum percentage of distributor's total purchase for the prior 12-month period	1.00%
Sales, net	$ 81,862,453	41,797,179	$ 33,274,702
Syringes
Revenue recognition
Sales, net	68,731,795	35,638,427	28,266,046
Blood Collection Products
Revenue recognition
Sales, net	2,363,887	2,715,697	1,422,842
Easy Point Needles
Revenue recognition
Sales, net	9,629,173	2,979,005	3,413,409
Other Products
Revenue recognition
Sales, net	1,137,598	464,050	172,405
Department of health and human
Revenue recognition
Sales, net	31,600,000
U.S.
Revenue recognition
Sales, net	73,803,806	31,897,924	28,646,574
U.S. \| Syringes
Revenue recognition
Sales, net		26,722,414	23,803,483
U.S. \| Blood Collection Products
Revenue recognition
Sales, net		2,130,767	1,365,936
U.S. \| Easy Point Needles
Revenue recognition
Sales, net		2,970,374	3,401,389
U.S. \| Other Products
Revenue recognition
Sales, net		74,369	75,766
U.S. government \| Department of health and human
Revenue recognition
Sales, net	31,634,343
U.S. government \| Department of health and human \| Syringes
Revenue recognition
Sales, net	31,634,343
North and South America sales (excluding U.S.)
Revenue recognition
Sales, net	6,893,150	8,248,990	3,597,444
North and South America sales (excluding U.S.) \| Syringes
Revenue recognition
Sales, net	5,733,116	7,863,796	3,521,823
North and South America sales (excluding U.S.) \| Blood Collection Products
Revenue recognition
Sales, net	8,450	6,313	8,805
North and South America sales (excluding U.S.) \| Easy Point Needles
Revenue recognition
Sales, net	86,816	7,996	252
North and South America sales (excluding U.S.) \| Other Products
Revenue recognition
Sales, net	1,064,768	370,885	66,564
Other international sales
Revenue recognition
Sales, net	1,165,497	1,650,265	1,030,684
Other international sales \| Syringes
Revenue recognition
Sales, net	917,478	1,052,217	940,740
Other international sales \| Blood Collection Products
Revenue recognition
Sales, net	239,329	578,617	48,101
Other international sales \| Easy Point Needles
Revenue recognition
Sales, net	235	635	11,768
Other international sales \| Other Products
Revenue recognition
Sales, net	8,455	$ 18,796	$ 30,075
Excluding HHS Order \| U.S.
Revenue recognition
Sales, net	42,169,463
Excluding HHS Order \| U.S. \| Syringes
Revenue recognition
Sales, net	30,446,858
Excluding HHS Order \| U.S. \| Blood Collection Products
Revenue recognition
Sales, net	2,116,108
Excluding HHS Order \| U.S. \| Easy Point Needles
Revenue recognition
Sales, net	9,542,122
Excluding HHS Order \| U.S. \| Other Products
Revenue recognition
Sales, net	$ 64,375

XML 62 R48.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Earnings per share
Diluted EPS calculated under the treasury stock method	131,347
Stock options excluded from calculation of diluted EPS		639,300	1,357,803
Net income (loss)	$ 24,223,013	$ 3,148,234	$ (1,339,943)
Preferred stock dividend requirements	(573,868)	(702,618)	(704,996)
Deemed contribution on extinguishment of preferred stock	2,975,708
Income (loss) applicable to common shareholders	$ 26,624,853	$ 2,445,616	$ (2,044,939)
Weighted Average common shares outstanding	33,169,307	32,672,475	32,666,454
Weighted Average common and common equivalent shares outstanding - assuming dilution	33,300,654	32,672,475	32,666,454
Basic earnings (loss) per share	$ 0.80	$ 0.07	$ (0.06)
Diluted earnings (loss) per share	$ 0.80	$ 0.07	$ (0.06)

XML 63 R49.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-insured employee benefit costs (Details)	12 Months Ended
	Dec. 31, 2020 USD ($)
Minimum
Additional insurance coverage	$ 100,000
Maximum
Additional insurance coverage	$ 1,000,000

XML 64 R50.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Technology Investment Agreement (TIA) (Details)	Jul. 01, 2020 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Research and development agreement with government funding amount	$ 53,664,286

XML 65 R51.htm IDEA: XBRL DOCUMENT

INVENTORIES (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
INVENTORIES
Raw materials	$ 1,358,552	$ 1,254,313
Finished goods	9,173,302	6,493,487
Inventory, gross	10,531,854	7,747,800
Inventory reserve	(297,208)	(297,208)
Inventory, net	$ 10,234,646	$ 7,450,592

XML 66 R52.htm IDEA: XBRL DOCUMENT

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($)	12 Months Ended
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Investments in equity securities
Investments in debt and equity securities, at fair value	$ 8,081,833	$ 7,771,660
Gross Unrealized
Cost	6,082,508	7,642,345
Gross Unrealized Gains	1,999,325	129,315
Level 1
Investments in equity securities
Investments in debt and equity securities, at fair value	8,004,489	6,708,746
Level 2
Investments in equity securities
Investments in debt and equity securities, at fair value	77,344	1,062,914
Equity securities
Investments in equity securities
Investments in debt and equity securities, at fair value	3,990,533
Gross Unrealized
Cost	2,098,144
Gross Unrealized Gains	1,892,389
Equity securities \| Level 1
Investments in equity securities
Investments in debt and equity securities, at fair value	3,990,533
Mutual funds and exchange traded funds
Investments in equity securities
Investments in debt and equity securities, at fair value	4,013,956	6,708,746
Gross Unrealized
Cost	3,909,364	6,592,345
Gross Unrealized Gains	104,592	116,401
Mutual funds and exchange traded funds \| Level 1
Investments in equity securities
Investments in debt and equity securities, at fair value	4,013,956	6,708,746
Certificates of deposit
Investments in equity securities
Investments in debt and equity securities, at fair value	77,344	1,062,914
Gross Unrealized
Cost	75,000	1,050,000
Gross Unrealized Gains	2,344	12,914
Certificates of deposit \| Level 2
Investments in equity securities
Investments in debt and equity securities, at fair value	$ 77,344	$ 1,062,914

XML 67 R53.htm IDEA: XBRL DOCUMENT

PROPERTY, PLANT, AND EQUIPMENT (Details) - USD ($)	12 Months Ended
PROPERTY, PLANT, AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Property, plant, and equipment
Property, plant and equipment, gross	$ 57,142,546	$ 36,023,997
Accumulated depreciation	(26,326,042)	(25,391,940)
Property, plant and equipment, net	30,816,504	10,632,057
Depreciation expense	832,069	851,673	$ 883,610
Land
Property, plant, and equipment
Property, plant and equipment, gross	261,893	261,893
Building and building Improvements
Property, plant, and equipment
Property, plant and equipment, gross	11,593,952	11,566,115
Production equipment
Property, plant, and equipment
Property, plant and equipment, gross	20,290,331	19,903,236
Office furniture and equipment
Property, plant, and equipment
Property, plant and equipment, gross	3,630,455	3,527,577
Construction in Progress
Property, plant, and equipment
Property, plant and equipment, gross	$ 21,365,915	$ 765,176

XML 68 R54.htm IDEA: XBRL DOCUMENT

LICENSE AGREEMENT (Details) - USD ($)	12 Months Ended
LICENSE AGREEMENT (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
LICENSE AGREEMENT
Fees	$ 44,854,100	$ 27,659,223	$ 23,052,900
Royalty expense to shareholder
LICENSE AGREEMENT
Fees	$ 5,476,306	3,449,822	2,944,102
Licensing Agreements
LICENSE AGREEMENT
Royalty percentage on sales	5.00%
Royalty percentage on sales of sublicense	50.00%
Royalty payable under the license agreement	$ 1,973,781	921,445
Gross sales upon which royalties are based	$ 109,526,118	$ 67,529,783	$ 58,882,042

XML 69 R55.htm IDEA: XBRL DOCUMENT

OTHER ACCRUED LIABILITIES (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
OTHER ACCRUED LIABILITIES
Prepayments from customers	$ 1,686,868	$ 998,601
Accrued professional fees	331,204	263,757
Current portion - preferred stock repurchase	1,092,282
Other accrued expenses	288,550	124,791
Total	$ 3,398,904	$ 1,387,149

XML 70 R56.htm IDEA: XBRL DOCUMENT

LONG-TERM DEBT (Details) - USD ($)	12 Months Ended
LONG-TERM DEBT (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Long-term debt
Long-term debt	$ 3,741,100	$ 2,638,994
Less: current portion	(1,030,763)	(260,939)
Long-term debt, net of current maturities	2,710,337	2,378,055
American First National Bank
Long-term debt
Original principal amount	$ 4,209,608	$ 4,209,608
Prime rate (as a percent)	0.25%	0.25%
Interest rate (as a percent)	5.00%
Long-term debt	$ 2,378,100	$ 2,638,994
Independent Bank [Member]
Long-term debt
Interest rate (as a percent)	1.00%	1.00%
Long-term debt	$ 1,363,000

XML 71 R57.htm IDEA: XBRL DOCUMENT

LONG-TERM DEBT - Future payments (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Future payments of long-term debt
2021	$ 1,030,763
2022	896,210
2023	304,120
2024	319,685
2025	336,488
Thereafter	853,834
Long term debt total	$ 3,741,100	$ 2,638,994

XML 72 R58.htm IDEA: XBRL DOCUMENT

OTHER LONG-TERM LIABILITIES (Details)	Dec. 31, 2020 USD ($)
OTHER LONG-TERM LIABILITIES
Stock repurchase	$ 2,034,373
Technology Investment Agreement (TIA)	22,444,324
Total	$ 24,478,697

XML 73 R59.htm IDEA: XBRL DOCUMENT

OTHER LONG-TERM LIABILITIES- Additional informtaion (Details)	12 Months Ended
	Dec. 31, 2020 USD ($) shares
OTHER LONG-TERM LIABILITIES
Net present value \| $	$ 3,303,330
Purchase price is payable \| $	$ 1,101,110
Series IV Preferred Stock
OTHER LONG-TERM LIABILITIES
Preferred shareholders as a result of private stock purchases \| shares	320,333
Series V Preferred Stock
OTHER LONG-TERM LIABILITIES
Preferred shareholders as a result of private stock purchases \| shares	25,000

XML 74 R60.htm IDEA: XBRL DOCUMENT

INCOME TAXES (Details) - USD ($)	1 Months Ended	12 Months Ended
INCOME TAXES (Details) - USD ($)	Jan. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Current tax provision (benefit)
Federal		$ 4,431,590		$ (13,318)
State		2,049,850	$ 7,875
Total current provision (benefit)		6,481,440	7,875	(13,318)
Deferred tax provision (benefit)
Federal		(3,428,399)
State		(1,202,807)
Total deferred tax provision (benefit)		(4,631,206)
Total income tax provision (benefit)		1,850,234	7,875	$ (13,318)
Tax benefits attributable to net operating losses for federal tax purposes	$ 100,000,000	23,300,000			$ 3,600,000
Deferred tax assets
Net operating loss carry forwards		198,675	5,748,724
Accrued expenses and reserves		824,920	573,382
Employee stock option expense		15,188	75,591
Nonemployee stock option expense		8,515	8,207
Inventory		98,748	110,455
Impairment			111,178
Deferred income - TIA contract		5,675,617
Unrealized Gain/Loss			30,434
Deferred tax assets		6,821,663	6,657,971
Deferred tax liabilities
Unrealized gains/losses		(508,197)
Property and equipment		(1,682,260)	(1,628,133)
Deferred tax liabilities		(2,190,457)	(1,628,133)
Net deferred assets		4,631,206	5,029,838
Valuation allowance			(5,029,838)
Net deferred tax assets		4,631,206
Increase (decrease) in valuation allowance		$ 5,029,838	$ (1,121,560)
Reconciliation of income taxes based on the federal statutory rate and the effective income tax rate
Income tax at the federal statutory rate (as a percent)		21.00%	21.00%	21.00%
State tax, net of federal tax (as a percent)		4.20%	2.00%	3.50%
Change in valuation allowance (as a percent)		(19.20%)	(35.60%)	(24.30%)
Permanent differences (as a percent)		(0.60%)		(0.30%)
Return-to-provision and other (as a percent)		1.70%	12.90%	(0.90%)
Tax Reform and Jobs Act tax rate change				0.10%	80.00%
Effective tax rate (as a percent)		7.10%	0.30%	(0.90%)
Minimum
Reconciliation of income taxes based on the federal statutory rate and the effective income tax rate
State and local income tax returns, period subject to examination		3 years
Maximum
Reconciliation of income taxes based on the federal statutory rate and the effective income tax rate
State and local income tax returns, period subject to examination		5 years

XML 75 R61.htm IDEA: XBRL DOCUMENT

DIVIDENDS (Details) - USD ($)	12 Months Ended
DIVIDENDS (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Dividends
Preferred dividends declared	$ 49,091	$ 54,800	$ 55,113
Series I, Class B
Dividends
Cumulative annual payments			49,250
Preferred dividends declared	10,041	48,000	48,625
Series II, Class B
Dividends
Cumulative annual payments	171,200	171,200
Preferred dividends declared	$ 39,050	$ 168,642	$ 171,200

XML 76 R62.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY (Details)	12 Months Ended
STOCKHOLDERS' EQUITY (Details)	Dec. 31, 2020 USD ($) item $ / shares shares	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2018 USD ($)
Stock repurchase program
Number of classes of preferred stock outstanding \| item	1
Dividend paid \| $	$ 216,642	$ 219,825	$ 220,450
Stock Redeemed or Called During Period, Value \| $	$ 107,250
Common stock authorized (in shares) \| shares	100,000,000	100,000,000
Common stock outstanding (in shares) \| shares	33,957,204	32,674,954
Preferred Class A
Stock repurchase program
Preferred stock authorized (in shares) \| shares	5,000,000
Preferred stock par value (in dollars per share)	$ 1.00
Preferred Class B
Stock repurchase program
Preferred stock authorized (in shares) \| shares	5,000,000	5,000,000
Preferred stock par value (in dollars per share)	$ 1.00
Number of series of preferred stock class B \| item	2
Preferred stock, remaining authorized shares to which series have Not been assigned \| shares	4,737,055
Series I, Class B
Stock repurchase program
Preferred stock par value (in dollars per share)	$ 1
Preferred stock outstanding (in shares) \| shares	0	96,000
Cumulative annual dividend payable quarterly (in dollars per share)	$ 0.50
Dividend paid \| $	$ 48,000	$ 48,625
Preferred stock dividend in arrears \| $	$ 0
Preferred stock redemption price (in dollars per share)	$ 7.50
Preferred stock conversion ratio	1
Number of shares of preferred stock converted into common stock \| shares	81,700	2,500
Stock Redeemed or Called During Period, Value \| $	$ 107,250
Amount per share the holders of the preferred stock entitled to in voluntary or involuntary dissolution, liquidation or winding up of the Company (in dollars per share)	$ 6.25
Series II, Class B
Stock repurchase program
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock outstanding (in shares) \| shares	156,200	171,200
Cumulative annual dividend payable quarterly (in dollars per share)	$ 1.00
Dividend paid \| $	$ 168,642	$ 171,200
Preferred stock dividend in arrears \| $	$ 0
Preferred stock redemption price (in dollars per share)	$ 15.00
Preferred stock conversion ratio	1
Amount per share the holders of the preferred stock entitled to in voluntary or involuntary dissolution, liquidation or winding up of the Company (in dollars per share)	$ 12.50
Number of consecutive quarters in which preferred stockholders have no voting right until dividends are in arrears	12
Right of preferred stock holders to elect a specified proportion of board of directors	0.33
Series III Preferred Stock
Stock repurchase program
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock outstanding (in shares) \| shares	106,745	129,245
Cumulative annual dividend payable quarterly (in dollars per share)	$ 1.00
Preferred stock dividend in arrears \| $	$ 4,037,000
Preferred stock redemption price (in dollars per share)	$ 15.00
Preferred stock conversion ratio	1
Number of shares of preferred stock converted into common stock \| shares	22,500
Exchanged for Common Stock \| shares	22,500
Amount per share the holders of the preferred stock entitled to in voluntary or involuntary dissolution, liquidation or winding up of the Company (in dollars per share)	$ 12.50
Series IV Preferred Stock
Stock repurchase program
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock outstanding (in shares) \| shares	0	342,500
Cumulative annual dividend payable quarterly (in dollars per share)	$ 1.00
Preferred stock dividend in arrears \| $	$ 101,000
Preferred stock redemption price (in dollars per share)	$ 11.00
Preferred stock conversion ratio	1
Exchanged for Common Stock \| shares	342,500
Amount per share the holders of the preferred stock entitled to in voluntary or involuntary dissolution, liquidation or winding up of the Company (in dollars per share)	$ 11.00
Series V Preferred Stock
Stock repurchase program
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock outstanding (in shares) \| shares	0	34,000
Cumulative annual dividend payable quarterly (in dollars per share)	$ 0.32
Preferred stock dividend in arrears \| $	$ 830,000
Preferred stock redemption price (in dollars per share)	$ 4.40
Number of shares of preferred stock converted into common stock \| shares	0	6,000
Exchanged for Common Stock \| shares	34,000
Amount per share the holders of the preferred stock entitled to in voluntary or involuntary dissolution, liquidation or winding up of the Company (in dollars per share)	$ 4.40
Preferred Class C
Stock repurchase program
Preferred stock authorized (in shares) \| shares	5,000,000
Preferred stock par value (in dollars per share)	$ 1.00
Common Stock
Stock repurchase program
Common stock authorized (in shares) \| shares	100,000,000	100,000,000
Common stock no par value (in dollars per share)	$ 0	$ 0
Common stock outstanding (in shares) \| shares	33,957,204	32,674,954
Number of shares issued for convertible preferred stock \| shares	462,395

XML 77 R63.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS - Share based compensation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Weighted-Average Exercise Price
Proceeds from Stock Options Exercised	$ 922,512
Stock Option Plan 2008
STOCK OPTIONS
Shares available for future issuance	0
Stock Option \| Director, officer, and employee
STOCK OPTIONS
Shares expired	8,300	661,003	505,216
Number of options
Outstanding at beginning of period (in shares)	639,300	1,300,303	1,805,519
Exercised (in shares)	(431,550)
Forfeited (in shares)	(8,300)	(661,003)	(505,216)
Outstanding at end of period (in shares)	199,450	639,300	1,300,303
Exercisable (in shares)	199,450	639,300	1,300,303
Weighted-Average Exercise Price
Outstanding at beginning of period (in dollars per share)	$ 2.12	$ 1.57	$ 1.51
Exercise price (in dollars per share)	(2.14)
Forfeited (in dollars per share)	(2.75)	(1.05)	(1.36)
Outstanding at end of period (in dollars per share)	2.05	2.12	1.57
Exercisable (in dollars per share)	$ 2.05	$ 2.12	$ 1.57
Stock Option \| Employees
STOCK OPTIONS
Options issued (in shares)	0	0	0
Stock Option \| Non Employees
STOCK OPTIONS
Options issued (in shares)	0	0	0
Shares expired		57,500
Number of options
Outstanding at beginning of period (in shares)		57,500	57,500
Forfeited (in shares)		(57,500)
Outstanding at end of period (in shares)			57,500
Exercisable (in shares)			57,500
Weighted-Average Exercise Price
Outstanding at beginning of period (in dollars per share)		$ 0.81	$ 0.81
Forfeited (in dollars per share)		$ (0.81)
Outstanding at end of period (in dollars per share)			0.81
Exercisable (in dollars per share)			$ 0.81
Stock Option \| Stock Option Plan 2008
Number of options
Granted (in shares)	3,649,508
Outstanding at end of period (in shares)	199,450

XML 78 R64.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS - Outstanding (Details) - USD ($)	12 Months Ended
STOCK OPTIONS - Outstanding (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Share-based compensation expense	$ 0	$ 0	$ 0
Assumed dividends	$ 0
Lower than market
Stock Options Outstanding
Shares Outstanding	199,450
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Shares Outstanding	199,450
Total intrinsic value of options exercised	$ 1,733,856
Director, officer, and employee \| Stock Option
Stock Options Outstanding
Exercise price (in dollars per share)	$ 2.05	$ 2.12	$ 1.57	$ 1.51
Director, officer, and employee \| Stock Option \| Exercise Price Dollars 1.05
Stock Options Outstanding
Exercise price (in dollars per share)	$ 1.05
Shares Outstanding	82,500
Weighted Average Remaining Contractual Life	5 years 11 months 27 days
Shares Exercisable	82,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Shares Outstanding	82,500
Director, officer, and employee \| Stock Option \| Exercise Price Dollars 2.75
Stock Options Outstanding
Exercise price (in dollars per share)	$ 2.75
Shares Outstanding	116,950
Weighted Average Remaining Contractual Life	5 years 8 months 12 days
Shares Exercisable	116,950
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Shares Outstanding	116,950
Non Employees \| Stock Option
Stock Options Outstanding
Exercise price (in dollars per share)			$ 0.81	$ 0.81

XML 79 R65.htm IDEA: XBRL DOCUMENT

401(k) PLAN (Details) - USD ($)	12 Months Ended
401(k) PLAN (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Defined Contribution Plan Disclosure [Line Items]
Employee service period	90 days
401(k) PLAN
Defined Contribution Plan Disclosure [Line Items]
Maximum percentage of compensation that employees may elect to contribute	88.00%
Employer Discretionary Contribution Amount	$ 162,008	$ 117,917	$ 145,146
401(k) PLAN \| Maximum
Defined Contribution Plan Disclosure [Line Items]
Employer Matching Contribution, Percent of Match	2.00%	2.00%	2.00%

XML 80 R66.htm IDEA: XBRL DOCUMENT

BUSINESS SEGMENT (Details) - USD ($)	12 Months Ended
BUSINESS SEGMENT (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Sales by geography
Sales, net	$ 81,862,453	$ 41,797,179	$ 33,274,702
U.S.
Sales by geography
Sales, net	73,803,806	31,897,924	28,646,574
Long-lived assets
Long-lived assets	30,751,259	10,542,688
North and South America sales (excluding U.S.)
Sales by geography
Sales, net	6,893,150	8,248,990	3,597,444
Other international sales
Sales by geography
Sales, net	1,165,497	1,650,265	$ 1,030,684
International
Long-lived assets
Long-lived assets	$ 65,245	$ 89,369

XML 81 R67.htm IDEA: XBRL DOCUMENT

LEASES (Details) - USD ($)	12 Months Ended
LEASES (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
LEASES
Remaining lease term	1 year
Operating lease cost	$ 103,312	$ 80,648
Cash outflows related to leases	106,101	80,648
Assets and liabilities associated with these leases in Balance Sheets
Other assets	$ 38,892	$ 82,359
Other assets [Extensible List]	us-gaap:OtherAssets	us-gaap:OtherAssets
Other accrued liabilities	$ 38,892	$ 82,359
Other accrued liabilities [Extensible List]	us-gaap:OtherAccruedLiabilitiesCurrent	us-gaap:OtherAccruedLiabilitiesCurrent
Other long-term liabilities [Extensible List]	us-gaap:OtherLiabilitiesNoncurrent	us-gaap:OtherLiabilitiesNoncurrent
Total operating lease liabilities	$ 38,892	$ 82,359

XML 82 R68.htm IDEA: XBRL DOCUMENT

PRIVATE EXCHANGES AND REDEMPTION (Details)	12 Months Ended
PRIVATE EXCHANGES AND REDEMPTION (Details)	Dec. 31, 2020 USD ($) $ / shares shares
Series I, Class B
Stock repurchase program
Redemption (in shares) \| shares	14,300
Preferred stock redemption price (in dollars per share) \| $ / shares	$ 7.50
Series II, Class B
Stock repurchase program
Preferred stock redemption price (in dollars per share) \| $ / shares	$ 15.00
Series III Preferred Stock
Stock repurchase program
Stock repurchased under the Common Stock repurchase plan (in shares) \| shares	22,500
Preferred stock redemption price (in dollars per share) \| $ / shares	$ 15.00
Series IV Preferred Stock
Stock repurchase program
Stock repurchased under the Common Stock repurchase plan (in shares) \| shares	342,500
Preferred stock redemption price (in dollars per share) \| $ / shares	$ 11.00
Series V Preferred Stock
Stock repurchase program
Stock repurchased under the Common Stock repurchase plan (in shares) \| shares	34,000
Preferred stock redemption price (in dollars per share) \| $ / shares	$ 4.40
Common Stock
Stock repurchase program
Aggregate cash consideration \| $	$ 3,786,000
Payment for repurchase of stock \| $	$ 482,670
Conversion of Preferred Stock into Common Stock (in shares) \| shares	754,000
Unpaid dividends in arrears waived \| $	$ 7,642,049

XML 83 R69.htm IDEA: XBRL DOCUMENT

PAYCHECK PROTECTION PROGRAM LOAN (Details) - Paycheck Protection Program, CARES Act	Aug. 17, 2020 USD ($)
Paycheck Protection Program
Principal amount, COVID-19	$ 1,363,000
Interest rate (as a percent)	1.00%

XML 84 R70.htm IDEA: XBRL DOCUMENT

PAYCHECK PROTECTION PROGRAM LOAN - Future payments (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Paycheck Protection Program
2021	$ 1,030,763
2022	896,210
Long term debt total	3,741,100	$ 2,638,994
Paycheck Protection Program, CARES Act
Paycheck Protection Program
2021	755,907
2022	607,093
Long term debt total	$ 1,363,000

XML 85 R71.htm IDEA: XBRL DOCUMENT

TECHNOLOGY INVESTMENT AGREEMENT (Details) $ in Millions		12 Months Ended
TECHNOLOGY INVESTMENT AGREEMENT (Details) $ in Millions	Jul. 01, 2020	Dec. 31, 2020 USD ($) ft²
TECHNOLOGY INVESTMENT AGREEMENT
Technology investment agreement term	10 years
Purchase of automated assembly and auxiliary equipment		$ 41.5
Area of land for existing properties \| ft²		27,800
Area of land for new warehouse \| ft²		55,000
Estimated cost of the controlled environment within existing properties		$ 6.4
Increase cost of controlled environment within manufacturing equipment		6.0
Estimated cost of the construction of the new warehouse		$ 5.8

XML 86 R72.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS (Details) - Subsequent Events - USD ($)	Mar. 16, 2021	Feb. 12, 2021
SUBSEQUENT EVENTS
Base period of performance		5 months
Base price for contract and purchase order		$ 54,217,800
Increase in value of contract		$ 92,772,680
Stock Option Plan 2021
SUBSEQUENT EVENTS
Common Stock, issued shares	2,000,000
Chief executive officer
SUBSEQUENT EVENTS
Granted (in shares)	1,000,000
General Counsel
SUBSEQUENT EVENTS
Granted (in shares)	250,000
Chief financial officer
SUBSEQUENT EVENTS
Granted (in shares)	100,000

XML 87 R73.htm IDEA: XBRL DOCUMENT

Schedule II-Schedule of Valuation and Qualifying Accounts (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Provision for Inventories
Movement in schedule of valuation and qualifying accounts
Balance at beginning of period	$ 297,208	$ 297,208	$ 594,939
Deductions			297,731
Balance at end of period	297,208	297,208	297,208
Provision for Accounts Receivables
Movement in schedule of valuation and qualifying accounts
Balance at beginning of period	146,382	149,665	101,872
Additions	125,000		47,793
Deductions	65,560	3,283
Balance at end of period	205,822	146,382	149,665
Deferred Tax Valuation
Movement in schedule of valuation and qualifying accounts
Balance at beginning of period	5,029,838	6,151,398	5,825,954
Additions			325,444
Deductions	5,029,838	1,121,560
Balance at end of period		5,029,838	6,151,398
Provision for Rebates
Movement in schedule of valuation and qualifying accounts
Balance at beginning of period	4,273,569	4,586,847	4,794,193
Additions	26,104,612	24,212,830	24,372,111
Deductions	26,566,256	24,526,108	24,579,457
Balance at end of period	3,811,925	4,273,569	4,586,847
Accounts payable
Movement in schedule of valuation and qualifying accounts
Balance at beginning of period	3,586,726	3,896,341
Balance at end of period	$ 3,435,352	$ 3,586,726	$ 3,896,341

EXCEL 88 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 90 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 277 408 1 false 65 0 false 7 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.vanishpoint.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - BALANCE SHEETS Sheet http://www.vanishpoint.com/role/StatementBalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.vanishpoint.com/role/StatementBalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - STATEMENTS OF OPERATIONS Sheet http://www.vanishpoint.com/role/StatementStatementsOfOperations STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.vanishpoint.com/role/StatementStatementsOfChangesInStockholdersEquity STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00400 - Statement - STATEMENTS OF CASH FLOWS Sheet http://www.vanishpoint.com/role/StatementStatementsOfCashFlows STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 10101 - Disclosure - BUSINESS OF THE COMPANY AND BASIS OF PRESENTATION Sheet http://www.vanishpoint.com/role/DisclosureBusinessOfCompanyAndBasisOfPresentation BUSINESS OF THE COMPANY AND BASIS OF PRESENTATION Notes 7 false false R8.htm 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 10301 - Disclosure - INVENTORIES Sheet http://www.vanishpoint.com/role/DisclosureInventories INVENTORIES Notes 9 false false R10.htm 10401 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS Sheet http://www.vanishpoint.com/role/DisclosureFairValueOfFinancialInstruments FAIR VALUE OF FINANCIAL INSTRUMENTS Notes 10 false false R11.htm 10501 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT Sheet http://www.vanishpoint.com/role/DisclosurePropertyPlantAndEquipment PROPERTY, PLANT, AND EQUIPMENT Notes 11 false false R12.htm 10601 - Disclosure - LICENSE AGREEMENT Sheet http://www.vanishpoint.com/role/DisclosureLicenseAgreement LICENSE AGREEMENT Notes 12 false false R13.htm 10701 - Disclosure - OTHER ACCRUED LIABILITIES Sheet http://www.vanishpoint.com/role/DisclosureOtherAccruedLiabilities OTHER ACCRUED LIABILITIES Notes 13 false false R14.htm 10801 - Disclosure - LONG-TERM DEBT Sheet http://www.vanishpoint.com/role/DisclosureLongTermDebt LONG-TERM DEBT Notes 14 false false R15.htm 10901 - Disclosure - OTHER LONG-TERM LIABILITIES Sheet http://www.vanishpoint.com/role/DisclosureOtherLongTermLiabilities OTHER LONG-TERM LIABILITIES Notes 15 false false R16.htm 11001 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.vanishpoint.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 11101 - Disclosure - INCOME TAXES Sheet http://www.vanishpoint.com/role/DisclosureIncomeTaxes INCOME TAXES Notes 17 false false R18.htm 11201 - Disclosure - DIVIDENDS Sheet http://www.vanishpoint.com/role/DisclosureDividends DIVIDENDS Notes 18 false false R19.htm 11301 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.vanishpoint.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 19 false false R20.htm 11401 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.vanishpoint.com/role/DisclosureRelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 20 false false R21.htm 11501 - Disclosure - STOCK OPTIONS Sheet http://www.vanishpoint.com/role/DisclosureStockOptions STOCK OPTIONS Notes 21 false false R22.htm 11601 - Disclosure - 401(k) PLAN Sheet http://www.vanishpoint.com/role/Disclosure401KPlan 401(k) PLAN Notes 22 false false R23.htm 11701 - Disclosure - BUSINESS SEGMENT Sheet http://www.vanishpoint.com/role/DisclosureBusinessSegment BUSINESS SEGMENT Notes 23 false false R24.htm 11801 - Disclosure - LEASES Sheet http://www.vanishpoint.com/role/DisclosureLeases LEASES Notes 24 false false R25.htm 11901 - Disclosure - PRIVATE EXCHANGES AND REDEMPTION Sheet http://www.vanishpoint.com/role/DisclosurePrivateExchangesAndRedemption PRIVATE EXCHANGES AND REDEMPTION Notes 25 false false R26.htm 12001 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN Sheet http://www.vanishpoint.com/role/DisclosurePaycheckProtectionProgramLoan PAYCHECK PROTECTION PROGRAM LOAN Notes 26 false false R27.htm 12101 - Disclosure - COVID-19 Sheet http://www.vanishpoint.com/role/DisclosureCovid19 COVID-19 Notes 27 false false R28.htm 12201 - Disclosure - TECHNOLOGY INVESTMENT AGREEMENT Sheet http://www.vanishpoint.com/role/DisclosureTechnologyInvestmentAgreement TECHNOLOGY INVESTMENT AGREEMENT Notes 28 false false R29.htm 12301 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.vanishpoint.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 29 false false R30.htm 12401 - Disclosure - Schedule II-Schedule of Valuation and Qualifying Accounts Sheet http://www.vanishpoint.com/role/DisclosureScheduleIiScheduleOfValuationAndQualifyingAccounts Schedule II-Schedule of Valuation and Qualifying Accounts Notes 30 false false R31.htm 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 31 false false R32.htm 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPolicies 32 false false R33.htm 30303 - Disclosure - INVENTORIES (Tables) Sheet http://www.vanishpoint.com/role/DisclosureInventoriesTables INVENTORIES (Tables) Tables http://www.vanishpoint.com/role/DisclosureInventories 33 false false R34.htm 30403 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) Sheet http://www.vanishpoint.com/role/DisclosureFairValueOfFinancialInstrumentsTables FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) Tables http://www.vanishpoint.com/role/DisclosureFairValueOfFinancialInstruments 34 false false R35.htm 30503 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT (Tables) Sheet http://www.vanishpoint.com/role/DisclosurePropertyPlantAndEquipmentTables PROPERTY, PLANT, AND EQUIPMENT (Tables) Tables http://www.vanishpoint.com/role/DisclosurePropertyPlantAndEquipment 35 false false R36.htm 30703 - Disclosure - OTHER ACCRUED LIABILITIES (Tables) Sheet http://www.vanishpoint.com/role/DisclosureOtherAccruedLiabilitiesTables OTHER ACCRUED LIABILITIES (Tables) Tables http://www.vanishpoint.com/role/DisclosureOtherAccruedLiabilities 36 false false R37.htm 30803 - Disclosure - LONG-TERM DEBT (Tables) Sheet http://www.vanishpoint.com/role/DisclosureLongTermDebtTables LONG-TERM DEBT (Tables) Tables http://www.vanishpoint.com/role/DisclosureLongTermDebt 37 false false R38.htm 30903 - Disclosure - OTHER LONG-TERM LIABILITIES (Tables) Sheet http://www.vanishpoint.com/role/DisclosureOtherLongTermLiabilitiesTables OTHER LONG-TERM LIABILITIES (Tables) Tables http://www.vanishpoint.com/role/DisclosureOtherLongTermLiabilities 38 false false R39.htm 31103 - Disclosure - INCOME TAXES (Tables) Sheet http://www.vanishpoint.com/role/DisclosureIncomeTaxesTables INCOME TAXES (Tables) Tables http://www.vanishpoint.com/role/DisclosureIncomeTaxes 39 false false R40.htm 31503 - Disclosure - STOCK OPTIONS (Tables) Sheet http://www.vanishpoint.com/role/DisclosureStockOptionsTables STOCK OPTIONS (Tables) Tables http://www.vanishpoint.com/role/DisclosureStockOptions 40 false false R41.htm 31703 - Disclosure - BUSINESS SEGMENT (Tables) Sheet http://www.vanishpoint.com/role/DisclosureBusinessSegmentTables BUSINESS SEGMENT (Tables) Tables http://www.vanishpoint.com/role/DisclosureBusinessSegment 41 false false R42.htm 31803 - Disclosure - LEASES (Tables) Sheet http://www.vanishpoint.com/role/DisclosureLeasesTables LEASES (Tables) Tables http://www.vanishpoint.com/role/DisclosureLeases 42 false false R43.htm 32003 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Tables) Sheet http://www.vanishpoint.com/role/DisclosurePaycheckProtectionProgramLoanTables PAYCHECK PROTECTION PROGRAM LOAN (Tables) Tables http://www.vanishpoint.com/role/DisclosurePaycheckProtectionProgramLoan 43 false false R44.htm 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts receivable (Details) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts receivable (Details) Details 44 false false R45.htm 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, plant and equipment (Details) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, plant and equipment (Details) Details 45 false false R46.htm 40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration risks (Details) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesConcentrationRisksDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration risks (Details) Details 46 false false R47.htm 40204 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue recognition (Details) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue recognition (Details) Details 47 false false R48.htm 40205 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share (Details) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesEarningsPerShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share (Details) Details 48 false false R49.htm 40206 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-insured employee benefit costs (Details) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSelfInsuredEmployeeBenefitCostsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-insured employee benefit costs (Details) Details 49 false false R50.htm 40207 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Technology Investment Agreement (TIA) (Details) Sheet http://www.vanishpoint.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTechnologyInvestmentAgreementTiaDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Technology Investment Agreement (TIA) (Details) Details 50 false false R51.htm 40301 - Disclosure - INVENTORIES (Details) Sheet http://www.vanishpoint.com/role/DisclosureInventoriesDetails INVENTORIES (Details) Details http://www.vanishpoint.com/role/DisclosureInventoriesTables 51 false false R52.htm 40401 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) Sheet http://www.vanishpoint.com/role/DisclosureFairValueOfFinancialInstrumentsDetails FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) Details http://www.vanishpoint.com/role/DisclosureFairValueOfFinancialInstrumentsTables 52 false false R53.htm 40501 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT (Details) Sheet http://www.vanishpoint.com/role/DisclosurePropertyPlantAndEquipmentDetails PROPERTY, PLANT, AND EQUIPMENT (Details) Details http://www.vanishpoint.com/role/DisclosurePropertyPlantAndEquipmentTables 53 false false R54.htm 40601 - Disclosure - LICENSE AGREEMENT (Details) Sheet http://www.vanishpoint.com/role/DisclosureLicenseAgreementDetails LICENSE AGREEMENT (Details) Details http://www.vanishpoint.com/role/DisclosureLicenseAgreement 54 false false R55.htm 40701 - Disclosure - OTHER ACCRUED LIABILITIES (Details) Sheet http://www.vanishpoint.com/role/DisclosureOtherAccruedLiabilitiesDetails OTHER ACCRUED LIABILITIES (Details) Details http://www.vanishpoint.com/role/DisclosureOtherAccruedLiabilitiesTables 55 false false R56.htm 40801 - Disclosure - LONG-TERM DEBT (Details) Sheet http://www.vanishpoint.com/role/DisclosureLongTermDebtDetails LONG-TERM DEBT (Details) Details http://www.vanishpoint.com/role/DisclosureLongTermDebtTables 56 false false R57.htm 40802 - Disclosure - LONG-TERM DEBT - Future payments (Details) Sheet http://www.vanishpoint.com/role/DisclosureLongTermDebtFuturePaymentsDetails LONG-TERM DEBT - Future payments (Details) Details 57 false false R58.htm 40901 - Disclosure - OTHER LONG-TERM LIABILITIES (Details) Sheet http://www.vanishpoint.com/role/DisclosureOtherLongTermLiabilitiesDetails OTHER LONG-TERM LIABILITIES (Details) Details http://www.vanishpoint.com/role/DisclosureOtherLongTermLiabilitiesTables 58 false false R59.htm 40902 - Disclosure - OTHER LONG-TERM LIABILITIES- Additional informtaion (Details) Sheet http://www.vanishpoint.com/role/DisclosureOtherLongTermLiabilitiesAdditionalInformtaionDetails OTHER LONG-TERM LIABILITIES- Additional informtaion (Details) Details 59 false false R60.htm 41101 - Disclosure - INCOME TAXES (Details) Sheet http://www.vanishpoint.com/role/DisclosureIncomeTaxesDetails INCOME TAXES (Details) Details http://www.vanishpoint.com/role/DisclosureIncomeTaxesTables 60 false false R61.htm 41201 - Disclosure - DIVIDENDS (Details) Sheet http://www.vanishpoint.com/role/DisclosureDividendsDetails DIVIDENDS (Details) Details http://www.vanishpoint.com/role/DisclosureDividends 61 false false R62.htm 41301 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.vanishpoint.com/role/DisclosureStockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details http://www.vanishpoint.com/role/DisclosureStockholdersEquity 62 false false R63.htm 41501 - Disclosure - STOCK OPTIONS - Share based compensation (Details) Sheet http://www.vanishpoint.com/role/DisclosureStockOptionsShareBasedCompensationDetails STOCK OPTIONS - Share based compensation (Details) Details 63 false false R64.htm 41502 - Disclosure - STOCK OPTIONS - Outstanding (Details) Sheet http://www.vanishpoint.com/role/DisclosureStockOptionsOutstandingDetails STOCK OPTIONS - Outstanding (Details) Details 64 false false R65.htm 41601 - Disclosure - 401(k) PLAN (Details) Sheet http://www.vanishpoint.com/role/Disclosure401KPlanDetails 401(k) PLAN (Details) Details http://www.vanishpoint.com/role/Disclosure401KPlan 65 false false R66.htm 41701 - Disclosure - BUSINESS SEGMENT (Details) Sheet http://www.vanishpoint.com/role/DisclosureBusinessSegmentDetails BUSINESS SEGMENT (Details) Details http://www.vanishpoint.com/role/DisclosureBusinessSegmentTables 66 false false R67.htm 41801 - Disclosure - LEASES (Details) Sheet http://www.vanishpoint.com/role/DisclosureLeasesDetails LEASES (Details) Details http://www.vanishpoint.com/role/DisclosureLeasesTables 67 false false R68.htm 41901 - Disclosure - PRIVATE EXCHANGES AND REDEMPTION (Details) Sheet http://www.vanishpoint.com/role/DisclosurePrivateExchangesAndRedemptionDetails PRIVATE EXCHANGES AND REDEMPTION (Details) Details http://www.vanishpoint.com/role/DisclosurePrivateExchangesAndRedemption 68 false false R69.htm 42001 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details) Sheet http://www.vanishpoint.com/role/DisclosurePaycheckProtectionProgramLoanDetails PAYCHECK PROTECTION PROGRAM LOAN (Details) Details http://www.vanishpoint.com/role/DisclosurePaycheckProtectionProgramLoanTables 69 false false R70.htm 42002 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN - Future payments (Details) Sheet http://www.vanishpoint.com/role/DisclosurePaycheckProtectionProgramLoanFuturePaymentsDetails PAYCHECK PROTECTION PROGRAM LOAN - Future payments (Details) Details 70 false false R71.htm 42201 - Disclosure - TECHNOLOGY INVESTMENT AGREEMENT (Details) Sheet http://www.vanishpoint.com/role/DisclosureTechnologyInvestmentAgreementDetails TECHNOLOGY INVESTMENT AGREEMENT (Details) Details http://www.vanishpoint.com/role/DisclosureTechnologyInvestmentAgreement 71 false false R72.htm 42301 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.vanishpoint.com/role/DisclosureSubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://www.vanishpoint.com/role/DisclosureSubsequentEvents 72 false false R73.htm 42401 - Disclosure - Schedule II-Schedule of Valuation and Qualifying Accounts (Details) Sheet http://www.vanishpoint.com/role/DisclosureScheduleIiScheduleOfValuationAndQualifyingAccountsDetails Schedule II-Schedule of Valuation and Qualifying Accounts (Details) Details http://www.vanishpoint.com/role/DisclosureScheduleIiScheduleOfValuationAndQualifyingAccounts 73 false false All Reports Book All Reports rvp-20201231.xml rvp-20201231.xsd rvp-20201231_cal.xml rvp-20201231_def.xml rvp-20201231_lab.xml rvp-20201231_pre.xml http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true ZIP 93 0001104659-21-044616-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-044616-xbrl.zip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�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end

Texas	75-2599762
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

511 Lobo Lane
Little Elm, Texas	75068-5295
(Address of principal executive offices)	(Zip Code)

Title of each class	Trading Symbol	Name of each exchange on which registered
Common	RVP	NYSE American LLC

Large accelerated filer ¨	Accelerated filer ¨
Non-accelerated filer x	Smaller reporting company x
	Emerging growth company ¨

PART I

Item 1. Business	1
Item 1A. Risk Factors	4
Item 1B. Unresolved Staff Comments	8
Item 2. Properties	8
Item 3. Legal Proceedings	9
Item 4. Mine Safety Disclosures	9

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities	9
Item 6. Selected Financial Data	11
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation	11
Item 7A. Quantitative and Qualitative Disclosures About Market Risk	16
Item 8. Financial Statements and Supplementary Data	F-1
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	17
Item 9A. Controls and Procedures	17
Item 9B. Other Information	17

PART III

Item 10. Directors, Executive Officers and Corporate Governance	18
Item 11. Executive Compensation	18
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	18
Item 13. Certain Relationships and Related Transactions, and Director Independence	18
Item 14. Principal Accounting Fees and Services	18

PART IV

Item 15. Exhibits, Financial Statement Schedules	18
Item 16. Form 10-K Summary	20
SIGNATURES	21

Period	Total Number of Shares	Average Price Paid Per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
December 31, 2020⁽¹⁾	14,300	$7.50⁽²⁾	14,300	0

	Number of securities to be issued upon exercise of outstanding options, warrants and rights		Weighted average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column(a))
Plan category	(a)		(b)		(c)
Equity compensation plans approved by security holders		199,450		$2.05		—
Total		199,450		$2.05		—

RETRACTABLE TECHNOLOGIES, INC. INDEX TO FINANCIAL STATEMENTS		Page

Report of Independent Registered Public Accounting Firm		F-3

Financial Statements:

Balance Sheets as of December 31, 2020 and 2019		F-5

Statements of Operations for the years ended December 31, 2020, 2019, and 2018		F-6

Statements of Changes in Stockholders’ Equity for the years ended December 31, 2020, 2019, and 2018		F-7

Statements of Cash Flows for the years ended December 31, 2020, 2019, and 2018		F-9

Notes to Financial Statements		F-10

Financial Statement Schedule:

Schedule II: Schedule of Valuation and Qualifying Accounts for the years ended December 31, 2020, 2019, and 2018		18

	Series I Class B				Series II Class B				Series III Class B				Series IV Class B				Series V Class B				Common
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares	Amount
Balance as of December 31, 2017	98,500		$98,500		171,200		$171,200		129,245		$129,245		342,500		$342,500		40,000		$40,000		32,666,454	$ —

Dividends	—		—		—		—		—		—		—		—		—		—		—	—

Net loss	—		—		—		—		—		—		—		—		—		—		—	—

Balance as of December 31, 2018	98,500		98,500		171,200		171,200		129,245		129,245		342,500		342,500		40,000		40,000		32,666,454	—

Conversion of Preferred Stock into Common Stock	(2,500	)	(2,500	)	—		—		—		—		—		—		(6,000	)	(6,000	)	8,500	—

Dividends	—		—		—		—		—		—		—		—		—		—		—	—

Net income	—		—		—		—		—		—		—		—		—		—		—	—

Balance as of December 31, 2019	96,000		96,000		171,200		171,200		129,245		129,245		342,500		342,500		34,000		34,000		32,674,954	—

Exchange of Preferred Stock for Common Stock	—		—		—		—		(22,500	)	(22,500	)	(342,500	)	(342,500	)	(34,000	)	(34,000	)	754,000	—

Conversion of Preferred Stock into Common Stock	(81,700	)	(81,700	)	(15,000	)	(15,000	)	—		—		—		—		—		—		96,700	—

Stock Option Exercises	—		—		—		—		—		—		—		—		—		—		431,550	—

Redemption	(14,300	)	(14,300	)	—		—		—		—		—		—		—		—		—	—

Dividends	—		—		—		—		—		—		—		—		—		—		—	—

Net income	—		—		—		—		—		—		—		—		—		—		—	—

Balance as of December 31, 2020	—		$ —		156,200		$156,200		106,745		$106,745		—		$ —		—		$ —		33,957,204	$ —

	Additional Paid-in Capital			Accumulated Deficit			Total

Balance as of December 31, 2017	$	62,092,206		$	(35,699,525	)	$	27,174,126

Dividends		(220,450	)		—			(220,450	)

Net loss		—			(1,339,943	)		(1,339,943	)

Balance as of December 31, 2018		61,871,756			(37,039,468	)		25,613,733

Conversion of Preferred Stock into Common Stock		8,500			—			—

Dividends		(219,512	)		—			(219,512	)

Net income		—			3,148,234			3,148,234

Balance as of December 31, 2019		61,660,744			(33,891,234	)		28,542,455

Exchange of Preferred Stock for Common Stock		(3,090,672	)		—			(3,489,672	)

Conversion of Preferred Stock into Common Stock		96,700			—			—

Stock Option Exercises		922,512			—			922,512

Redemption		(92,950	)		—			(107,250	)

Dividends		(210,933	)		—			(210,933	)

Net income		—			24,223,013			24,223,013

Balance as of December 31, 2020	$	59,285,401		$	(9,668,221	)	$	49,880,125

		For the year ended December 31, 2020:
Geographic Segment		Syringes		Blood Collection Products		EasyPoint^® Needles		Other Products		Total Product Sales
U.S. sales (excluding HHS Order)	$	30,446,858	$	2,116,108	$	9,542,122	$	64,375	$	42,169,463
HHS Order sales to U.S. government		31,634,343		—		—		—		31,634,343
North and South America sales (excluding U.S.)		5,733,116		8,450		86,816		1,064,768		6,893,150
Other international sales		917,478		239,329		235		8,455		1,165,497
Total	$	68,731,795	$	2,363,887	$	9,629,173	$	1,137,598	$	81,862,453

		Years Ended December 31,
		2020		2019		2018
Net income (loss)	$	24,223,013	$	3,148,234	$	(1,339,943	)
Preferred stock dividend requirements		(573,868	)	(702,618	)	(704,996	)

		December 31, 2020
		Level 1		Level 2		Level 3		Total
Equity securities	$	3,990,533	$	—	$	—	$	3,990,533
Mutual funds and exchange traded funds		4,013,956		—		—		4,013,956
Certificates of deposit		—		77,344		—		77,344
	$	8,004,489	$	77,344	$	—	$	8,081,833

		December 31, 2019
		Level 1		Level 2		Level 3		Total
Mutual funds and exchange traded funds	$	6,708,746	$	—	$	—	$	6,708,746
Certificates of deposit		—		1,062,914		—		1,062,914
	$	6,708,746	$	1,062,914	$	—	$	7,771,660

		December 31,
		2020		2019
Prepayments from customers	$	1,686,868	$	998,601
Accrued professional fees		331,204		263,757
Current portion – preferred stock repurchase		1,092,282		—
Other accrued expenses		288,550		124,791
Total	$	3,398,904	$	1,387,149

Exercise Prices		Shares Outstanding		Weighted Average Remaining Contractual Life		Shares Exercisable
$	1.05		82,500		5.99		82,500
$	2.75		116,950		5.70		116,950

(a)	(1)	All financial statements: See Retractable Technologies, Inc. Index to Financial Statements on Page F-2.

	(2)	Those financial statement schedules required to be filed by Item 8 of this form, and by paragraph (b) below. Schedule II-Schedule of Valuation and Qualifying Accounts for the years ended December 31, 2020, 2019, and 2018:

	Balance at beginning of period		Additions		Deductions		Balance at end of period
Provision for Inventories
Fiscal year ended 2018	$	594,939	$	—	$	297,731	$	297,208
Fiscal year ended 2019	$	297,208	$	—	$	—	$	297,208
Fiscal year ended 2020	$	297,208	$	—	$	—	$	297,208

Provision for Accounts Receivable
Fiscal year ended 2018	$	101,872	$	47,793	$	—	$	149,665
Fiscal year ended 2019	$	149,665	$	—	$	3,283	$	146,382
Fiscal year ended 2020	$	146,382	$	125,000	$	65,560	$	205,822

Deferred Tax Valuation
Fiscal year ended 2018	$	5,825,954	$	325,444	$	—	$	6,151,398
Fiscal year ended 2019	$	6,151,398	$	—	$	1,121,560	$	5,029,838
Fiscal year ended 2020	$	5,029,838	$	—	$	5,029,838	$	—

Exhibit No.		Description of Document
3(i)		Restated Certificate of Formation with Certificates of Designation, Preferences, Rights and Limitations of Class B Preferred Stock (all Series)⁽¹⁾

3(ii)		Fourth Amended and Restated Bylaws of RTI⁽²⁾

4(i)		Restated Certificate of Formation with Certificates of Designation, Preferences, Rights and Limitations of Class B Preferred Stock (all Series) ⁽³⁾

4(vi)		Description of Securities⁽⁴⁾

10.1		Sample United States Distribution Agreement⁽⁵⁾

10.2		Sample Foreign Distribution Agreement⁽⁶⁾

10.3		Employment Agreement between RTI and Thomas J. Shaw dated as of January 1, 2008 (This is a management compensation contract.)⁽⁷⁾

10.4		Technology License Agreement between Thomas J. Shaw and RTI dated the 23^rd day of June, 1995⁽⁸⁾

10.5		First Amendment to Technology License Agreement between Thomas J. Shaw and RTI dated the 3rd day of July, 2008⁽⁹⁾

10.6		Second Amendment to Technology License Agreement between Thomas J. Shaw and Retractable Technologies, Inc. dated as of the 7th day of September, 2012⁽¹⁰⁾

10.7		Retractable Technologies, Inc. First Amended 2008 Stock Option Plan⁽¹¹⁾

10.8		Voting Agreement Between Thomas J. Shaw and Suzanne August dated November 8, 2006 ⁽¹²⁾

10.9		Technology Investment Agreement between RTI and U.S. Department of Defense dated July 1, 2020 ⁽¹³⁾

Exhibit No.		Description of Document
10.10		Agreement for the Purchase and Sale of Preferred Stock between RTI and Sovana Cayman Islands dated as of August 31, 2020⁽¹⁴⁾

10.11		U.S. Small Business Administration Note dated April 17, 2020⁽¹⁵⁾

10.12		2021 Stock Option Plan⁽¹⁶⁾

14		Retractable Technologies, Inc. Code of Business Conduct and Ethics⁽¹⁷⁾

31.1		Certification of Principal Executive Officer⁽¹⁸⁾

31.2		Certification of Principal Financial Officer⁽¹⁹⁾

32		Section 1350 Certifications⁽²⁰⁾

101		The following materials from this report, formatted in XBRL (eXtensible Business Reporting Language): (i) Balance Sheets as of December 31, 2020, and 2019, (ii) the Statements of Operations for the years ended December 31, 2020, 2019, and 2018, (iii) the Statements of Changes in Stockholders’ Equity for the years ended December 31, 2020, 2019, and 2018, (iv) the Statements of Cash Flows for the years ended December 31, 2020, 2019, and 2018, and (v) Notes to Financial Statements.⁽²¹⁾

		RETRACTABLE TECHNOLOGIES, INC.
		(Registrant)

	By:	/s/ Thomas J. Shaw
		THOMAS J. SHAW
		CHAIRMAN, PRESIDENT, AND
		CHIEF EXECUTIVE OFFICER

		March 31, 2021


	/s/John W. Fort III
	JOHN W. FORT III
	VICE PRESIDENT, CHIEF FINANCIAL OFFICER, PRINCIPAL ACCOUNTING OFFICER, TREASURER, AND DIRECTOR

	March 31, 2021

	/s/ Amy Mack
	AMY MACK
	DIRECTOR

	March 31, 2021

	/s/ Marco Laterza
	MARCO LATERZA
	DIRECTOR

	March 31, 2021

	/s/ Walter O. Bigby, Jr.
	WALTER O. BIGBY, JR.
	DIRECTOR

	March 31, 2021

	/s/ Darren E. Findley
	DARREN E. FINDLEY
	DIRECTOR

	March 31, 2021

Director	Address	Term Expires
Thomas J. Shaw	511 Lobo Lane PO Box 9 Little Elm, TX 75068-0009	2022

John W. Fort III	511 Lobo Lane PO Box 9 Little Elm, TX 75068-0009	2022

Marco Laterza	511 Lobo Lane PO Box 9 Little Elm, TX 75068-0009	2021

Amy Mack	511 Lobo Lane PO Box 9 Little Elm, TX 75068-0009	2021

Walter O. Bigby, Jr.	511 Lobo Lane PO Box 9 Little Elm, TX 75068-0009	2022

Darren E. Findley	511 Lobo Lane PO Box 9 Little Elm, TX 75068-0009	2021

		shares of the Corporation entitled to vote generally in the election of directors voting together as a single class. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director; provided, however, that the term of existing Directors may be shortened to comply with this Article IX and/or the Texas Business Organizations Code. The directors shall be divided into two classes as nearly equal in number as possible, where the term of office of the first class expired at the 2001 annual meeting of stockholders, and the term of office of the second class expired at the 2002 annual meeting of stockholders, and with the members of each class to hold office until their successors shall have been elected and qualified. At each annual meeting of stockholders following such initial classification and election, directors elected to succeed those directors shall be elected for a term of office to expire at the second succeeding annual meeting of stockholders after their election.

	b)	Newly Created Directorships and Vacancies. Vacancies of generally elected directors may be filled by a majority vote of the remaining generally elected directors, though less than a quorum, or by a sole remaining generally elected director. Vacancies of directors elected pursuant to a dividend default election by preferred shareholders shall be filled by the remaining directors so elected or by a sole remaining director elected by such shareholders, if any. In the event that no directors elected pursuant to a dividend default election remain, the vacancy may be filled by a vote of those shareholders that originally elected the director whose office is vacant.

THOMAS J. SHAW
PRESIDENT, CHAIRMAN, AND
CHIEF EXECUTIVE OFFICER

JOHN W. FORT III
VICE PRESIDENT, CHIEF FINANCIAL
OFFICER AND PRINCIPAL
ACCOUNTING OFFICER

	JOHN W. FORT III
	VICE PRESIDENT, CHIEF FINANCIAL
	OFFICER, AND PRINCIPAL
	ACCOUNTING OFFICER